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The taro virome has been documented to include a few currently known viral species. 
Among these, Taro vein chlorosis nucleorhabdovirus (TaVCV) is a virus that has been 
discovered in several different countries across the South Pacific, and, as of 2013, has started to 
infect taro in Hawaii. Efforts to detect TaVCV in infected taro across regional variants has 
remained a challenge, as the regional genomic diversity of this virus has been noted to reach as 
high as 21%. A previous study conducted on Hawaiian TaVCV isolates has determined a very 
low diversity among local variants, so a sampling method to take infected taro samples from 
Hawaii, Samoa, Guam, Palau and Vanuatu was conducted to determine the genomic sequences 
from each of these regions and perform a phylogenetic analysis of these variants. Next-
generation sequencing (NGS) performed on double-stranded (ds)RNA found TaVCV genomes 
that diversified by up to 20% compared to the TaVCV sequence available from GenBank, 
derived from a Fijian isolate. Additionally, NGS also contributed to the discovery of a unique 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
Taro, Colocasia esculenta (L.) Schott 
1.0 Botany and Ecology 
1.1 History of Classification 
 Colocasia esculenta, commonly referred to as taro, is a member of the genus Colocasia, 
under the family Araceae. Over many generations, this plant has been cultivated in many 
different locations globally and has therefore resulted in several different varieties and 
agronomical cultivars. This has resulted in many different taxonomic synonyms for Colocasia 
esculenta, which arose from many different attempts and disagreements between botanists 
regarding the classification of taro (Lim, 2014; Onwueme, 1999). 
 Originally, two unique species, Arum colocasia, and Arum esculentum were described by 
Linnaeus in 1753, though the genus Colocasia was later described by Schott and the species 
described by Linnaeus were both moved under that genus and renamed Colocasia antiquorum 
and Colocasia esculenta, respectively (Hill, 1939). Later, C. acris (formerly described as 
Calladium acre) was added to the genus in 1810 by Schott, followed by C. nymphaeifolia in 
1841 by Kunth, then C. fontanesii in 1854 by Schott and C. euchlora in the same year by C. 
Koch and Sello. By then, the number of described species in the genus Colocasia rose to six. 
 Schott would then re-organize the classification in 1856, recognizing Colocasia 
antiquorum as the only species, while the others were then ranked as varieties of that species. 
The varieties ‘typica’ and ‘illustris’ in 1879 by Engler and ‘aquatilis’ and ‘globulifera’ in 1920 
by Engler and Krause were subsequently described. The changes that Schott made in re-
organizing the genus back in 1856 were considered unlawful by the International Rules of 
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Botanical Nomenclature (also referred to as the “Vienna Rules” of 1906), as an older species 
could not be changed to being considered a variety of a species that would be described at a later 
date. Accordingly, future literature would describe C. esculenta as the main species, while C. 
antiquorum would then be considered as a variety of that species (Hill, 1939). Of the varieties of 
the taro that are cultivated, the common varieties used include Colocasia esculenta (L.) Schott 
var. ‘antiquorum’ and Colocasia esculenta (L.) Schott var. ‘esculenta’ (Purseglove, 1973). 
 The ‘esculenta’ variety of C. esculenta has corms, which are the edible underground 
stems, and cormels, which are smaller bud-like structures. Additionally, the leaves and petioles 
(above the ground) may also be consumed (Alercia, 2013). The ‘antiquorum’ variety, by 
comparison, has a small globular central corm, from which several cormels that are relatively 
large arise. Agronomically, the ‘esculenta’ variety is referred to as the dasheen type of taro, 
whereas the ‘antiquorum’ variety is referred to as the eddoe type. The dasheen type comprises 
the majority of the taro that is cultivated in the Asia-Pacific region (Onwueme, 1999). 
 As taro has widespread cultivation, several different cultivars are grown around the 
world, and as such, these different cultivars can have varying physiological characteristics, 
which can include the size and/or shape of the corm and leaves, as well as the texture and color 
of the leaves and petioles. Some additional contributing factors to distinguishing cultivars 
include agronomic or culinary preference (Onwueme, 1999). Historical records establish that 
Hawaiian agriculture, even before European contact in 1778, involved approximately 300 
cultivars of taro, which included both wetland and dryland types. Based on their morphology and 
ability to grow in certain environmental conditions, these cultivars were separated accordingly 
(Cho, Yamakawa, & Hollyer, 2007; Jacobs, 2011), though it was stated by Whitney et al. (1939) 




1.2 Origin and Distribution 
 The origin of taro was speculated to be in South Central Asia; specifically, a high 
likelihood that its origin is from India or the Malay Peninsula (Hill, 1939; Whitney et al., 1939). 
A karyotypic study would later reveal that the origin of taro is in northeastern India (Kuruvilla & 
Singh, 1981). Taro would then spread to the rest of Southeast Asia, as well as China and Japan. 
Seafaring voyagers would contribute to the spread of taro to the Pacific Islands. A westward 
spread would also occur simultaneously to Egypt and the Eastern Mediterranean, as well as 
Africa and, from there, to the Caribbean and the Americas (Lee, 1999; Matthews, 1995, 2004; 
Onwueme, 1999; Plucknett, 1983). The primary origin of the introduction of C. esculenta into 
Hawaii is considered to be the Polynesian migration to Hawaii (Greenwell, 1947). 
 A high degree of genetic diversity was observed in Asian taro as well as a characteristic 
gene pool in the Pacific that was observed during an isozyme variation study of Asian and 
Oceanian taro cultivars. Further, the results of the study indicated that the Indonesian cultivars 
have the highest genetic variation and that a narrow base within that gene pool could be the 
origin of many Pacific cultivars (Lebot & Aradhya, 1991). Further studies seem to support these 
findings, including a study done by Kreike et al. (2004) using amplified fragment length 
polymorphism (AFLP-)PCR. These research efforts, which yielded enough data to perform a 
phylogenetic analysis, helped to conclusively separate 255 taro accessions and assort them into 
Asian and Pacific gene pools. 
 Though the variety ‘Lehua Maoli’ had been the preferred variety for cultivation in 
Hawaii, modern production of taro primarily consists of the varieties ‘Maui lehua,’ ‘Moi,’ and 
‘Bun Long,’ and hybrids between Hawaiian and Palauan varieties (Cho et al., 2007). Despite 
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records indicating the availability of many different varieties, there is a clear preference for some 
varieties which may have been reinforced due to factors which include large-scale commercial 
farming, palatability, and research studies promoting or utilizing certain varieties in preference 
over others. Thus, there is an idea that the cultivation of taro that had once been considered a 
sacred commodity has transformed into a crop that is raised procedurally in a way that deviates 
from tradition (Jacobs, 2011). 
 
1.3 Morphology and Anatomy 
 Taro is a herbaceous perennial plant that can grow up to 1-2 meters tall and the spread of 
its canopy can span a comparable area. The main stem structure of taro is represented by the 
central corm grown underground. The corm is large in the dasheen type of taro and its shape 
resembles that of a cylindrical top, with features of rough ridges, lumps, and fibrous gangling 
roots. The dimensions of a corm can measure up to 30 cm in length and 15 cm in diameter, and 
typically weigh 1-2 lbs, but can range up to eight pounds in weight (Moore & Lawrence, 2003; 
Onwueme, 1999). 
 Most parts of taro contain idioblasts, which are cells that contain raphides (needle-shaped 
crystals composed of calcium oxalate). Consumption of plants that contain raphides can result in 
edema, vesicle formation, and dysphagia, as well as an onset of burning and painful stinging to 
the throat and mouth for a duration of up to two weeks (Watson et al., 2005); due to these health 
risks, it is not recommended to eat any such plants uncooked. The skin that covers the corm is 
brown with some patches of pink or white and the woodiness and density of the corm both 
increase with age. Smaller cormels (which are also edible) or tubers can be produced off the side 
of the main corm in certain varieties of C. esculenta. Some taro plants can produce runners as 
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well, which grow horizontally with interspersed intervals of rooting down to induce new 
standing plants (Moore & Lawrence, 2003; Onwueme, 1999). These morphological 
characteristics are also supplemented with a detailed passage by Whitney et al. (1939): 
 
“Extremely variable, succulent, glabrous herb, 4 to 18 dm. tall. Stem a subterranean 
corm with scaly outer bark and thin, usually highly colored cortex, single or 
branching from the apex, with conspicuous leaf-scar rings, producing cormels (oha) 
or rhizomes as offshoots. Petioles 4 to 18 dm. long, erect or spreading, sheathing at 
base with sinus to about midway, uniformly light or dark green to variously highly 
colored, striped, or flecked. Blades 25 to 85 cm. long, 20 to 60 cm. wide, usually 
peltate, ovate to more or less sagittate, the apex acuminate, a dark-colored spot 
known as piko on the upper surface at the point of junction with petiole. 
Inflorescences 2 to 5 together in the leaf axils, the peduncles 15 to 50 cm. long, 
each spadix enclosed within a spathe. Spathes oblong-lanceolate, divided by a 
transverse constriction into two unequal parts, the lower part 3 to 5 cm. long, 
loosely or tightly convolute, more or less fleshy, tubular, the upper part 15 to 35 
cm. long, usually tightly but sometimes loosely convolute, lanceolate. Spadix 6 to 
14 cm. long, with female flowers at the base, consisting of a few obovoid or 
ellipsoid ovaries 0.5 to 1.5 mm. in diameter, the stigma sessile, capitate; constricted 
above the female flowers and beset over a length of 2 to 5 cm. with light yellow 
sterile flowers; above the sterile flowers and over a length of 2 to 4 cm. beset with 
male flowers consisting of 2 to 6 sessile anthers which are fused into an obconical 
synandrium; with yellow constricted, obtuse or acute sterile appendage at apex. 
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Fruit a berry, 3 to 5 mm. across, ellipsoid. Seed 1.2 to 1.5 mm. long, 0.7 to 1 mm. 
wide, hard, ovoid.” 
 
2.0 Ethnobotany of Taro 
2.1 Food Security, Nutritional and Economic Importance of Taro 
 Throughout the Pacific Island Countries (PICs) and some West African countries, taro is 
widely considered a staple crop and therefore plays a significant role in food security, nutrition, 
and economy in countries that depend on it. Taro had historically been considered the most 
important crop in the Hawaiian Islands (Moore & Lawrence, 2003), though it no longer holds 
that status in modern Hawaiian agriculture, especially when compared to coffee, nuts, and seed 
corn (Gomes, 2012). Despite this, taro still plays a significant role in many of the PICs. 
 The corm of the taro is often included with many vegetable and meat preparations, with 
one popular method being taro baked in a dug-out earth oven together with other staple crops and 
meat, done during celebrations, festivities, and traditional ceremonies; this method is referred to 
as “imu” in Hawaii, “umu” in Samoa and “lovo” in Fiji (Deo et al., 2009). Palusami, or young 
taro leaves cooked together with coconut cream, meat or tuna, is a delicacy prepared with the 
aforementioned method. Additionally, the inflorescence of taro can be a delicacy itself in certain 
Pacific or Asian cultures (Rao et al. 2010). 
 Poi, a traditional dish of fermented or unfermented paste made from mashing cooked 
corm together with water until the paste has the desired consistency, is a staple of Hawaiian food 
culture (Lee, 1999; Potgieter, 1940). Lu’au, another traditional Hawaiian dish, is made by 
cooking meat with young taro leaves and tops and coconut cream (Uchida et al., 2008). Some 
additional applications of taro include processing corm starch into flour (Payne, Ley, & Akau, 
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1941), which has had some use in the baking industry (Ammar, Hegazy, & Bedeir, 2009), and 
also into taro chips (Hollyer, Paull, & Huang, 2000). Despite these applications, taro cultivation 
has steadily decreased over the years and is now often considered an underutilized commodity 
(Alercia, 2013), but its importance and role in culture and commercial use places pressure on 
researchers to maintain and uphold the food security of taro. 
 Due to the abundance of complex carbohydrates in taro corm, it is considered a primary 
source of starch comparable to that of potatoes. In contrast, taro starch has a high digestibility 
value of 98.8% which is due to the miniature size of its starch granules which are approximately 
ten times smaller than that of starch in potatoes (Jane et al., 1992). This property makes it an 
ideal ingredient for both infant formula and canned baby foods. For individuals that may have 
allergies to cereals and milk, taro can be a sufficient substitute (Lee, 1999; Moore & Lawrence, 
2003). The leaves are high in protein while the corm contains some dietary fiber and a low 
amount of fat. Both contain the essential vitamins B1, B2, B6, B9, C and E, and some minerals, 
including calcium, copper, magnesium, iron, potassium, phosphorus, and manganese (Alcantara, 
Hurtada, & Dizon, 2013; Alercia, 2013; Payne et al., 1941; Potgieter, 1940; Temesgen & Retta, 
2015). The strong nutritional benefit has also motivated researchers to recommend the use of taro 
as a key ingredient in animal feed (Adejumo, Babalola, & Alabi, 2013; Moore & Lawrence, 
2003). 
 Besides the nutritional benefit of taro, it also plays a role in traditional and herbal 
medicine in several cultures. In Africa, leaves are used as a demulcent for wounds, sores, and 
boils, as well as to clot blood to prevent excessive bleeding; in Indonesia, the stem is used for 
neutralizing poisons from snakes, and rheumatism and acne are treated using the extract from 
roots (Abbas, 2011). Leaves and corms were prepared in the Philippines with a unique 
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preparation method to help alleviate pain for women undergoing childbirth, while some tribes 
also used morning dew on the leaves as an eyewash or had a woman suffering from 
dysmenorrhea sit on a leaf to help reduce the pain; reduction of bleeding was also treated using 
styptic petiole extracts. In Hawaii, one approach to an anti-inflammatory treatment to treat 
conditions such as fever was to drink raw taro juice mixed with sugar. Poi has some additional 
utility as a probiotic (Brown & Valiere, 2004). 
 As one of the few plants that have both the parts above-ground and underground 
consumed, taro is a very important fresh crop in domestic markets across most of the PICs 
(McGregor et al., 2011). Export markets were recently opened in a few countries, including Fiji, 
Samoa, Tonga, and Vanuatu, due to a recent revamp in taro production (Sami, 2011). FAO 
statistics show that, in 2017, worldwide production of taro is approximately 10 million tonnes, 
where 4% (approximately 409,000 tonnes) of that production originates from Oceania. Fiji was 
the most active country in terms of exports, in which a value of 20 million FJD per annum was 
attributed to nearly 95% of total exports (McGregor et al., 2011). Papua New Guinea (PNG), 
which is the largest taro producer in Oceania and produces more than half the amount of taro 
associated with Oceania, prefers the domestic sale of taro, which accounts for the low export 
figures. Additionally, a high shipping cost to trading partners causes export prices to be high, 
which prevents prices from being competitive compared to Fiji. In Hawaii, production of taro 
was approximately 1,350 tonnes in 2018 valued at around 1.97 million USD (“USDA Crop 
Production 2018 Summary,” 2019, “USDA Crop Values 2018 Summary,” 2019). 
 
2.2 Socio-Cultural Importance of Taro in Hawaii and Oceania 
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 Though its origins can be traced back to Asia, taro remains a critical component in the 
culture of the Hawaiian Islands and the PICs, starting with the early cultivation of taro in lo’i, 
flooded taro patches, as daily routine and the foundation of civilization for native Hawaiians 
(Greenwell, 1947). Agriculture and medicine were not the only roles that taro played a part in, as 
taro would also have a central role in beliefs about creation. 
 “Kumulipo” is a Hawaiian chant that depicts a narrative in which taro was the plant that 
was the progenitor of Hawaiians and features the legend of the Earth Mother, Papa, and the Sky 
Father, Wakea, and their child Ho’ohokukalani, who was to be the most beautiful and charming 
woman ever. Later in life, Ho’ohokukalani had a child, Haloa-naka, but the child was stillborn 
and was buried. From the burial site arose a kalo (the Hawaiian nomenclature for taro) plant, 
which provided nourishment for the second child, Haloa. Haloa-naka would live on through the 
vegetative propagation of taro, which made it a holy plant to be respected and treated as an elder 
sibling. Hawaiians would then base their lineage on the younger brother, Haloa (Cho et al., 2007; 
Jacobs, 2011; Uchida et al., 2008). 
 Prayers were regularly performed to seek blessings from the Gods for each new activity 
performed during a farming cycle, which would honor and signify the work and effort put into 
farming to produce taro. Rather than being focused on profit (which the early Hawaiians did not 
utilize), the early agricultural system played a role in feeding people, maintaining religious 
practices and beliefs, reinforcing tradition, and sustaining customary obligations (Uchida et al., 
2008). Despite the commercialization of taro, the spiritual connection and symbolism of the taro 
plant continue to persist even today, and this idea is illustrated and reinforced through taro as a 
core art theme present throughout the state of Hawaii (Deo et al., 2009). 
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 Eduardo Trujillo, a plant pathologist associated with the College of Tropical Agriculture 
and Human Resources (CTAHR) at the University of Hawaii at Manoa (UHM), introduced three 
improved taro varieties in 2002 that came as a result of a breeding experiment that had started in 
the early 1990s (“CTAHR and Taro,” 2009), and an effort to patent these varieties to UHM was 
undertaken. These varieties contained a desirable phenotype correlated with that of the ‘Maui 
Lehua’ variety (one of the cultivars of the royal Lehua family of Hawaiian cultivars), as well as a 
notable resistance to taro leaf blight (TLB) (Trujillo, Menezes, Cavaletto, Shimabuku, & Fukuda, 
2002). The cultural attachments and sentiments about taro caused a discordance with certain 
communities regarding the patents, which led to protests in 2006. Suitably, UHM relinquished its 
patent rights and made the three varieties available to the public (“CTAHR and Taro,” 2009). In 
2007, an announcement was made in which kalo was declared as the state plant. 
Controversy surrounded the use of genetically modified taro in cultivation, and many 
pushed for the Legislature of the State of Hawaii to pass bills HB704 and SB958, which would 
start a ten-year moratorium prohibiting the use of genetically modified taro. Accordingly, a ban 
on genetically engineered taro and coffee on the Big Island was issued by the Hawaii County 
Council by passing a bill in 2008 which forbade the experimentation, release, and propagation of 
genetically engineered taro and coffee within the county. Maui County Council would soon 
emulate this notion in 2009 (Jacobs, 2011). 
 Palauans also have a strong cultural attachment to taro, which is demonstrated through its 
use as an emblem of exchange and gratitude during many different events, which include birth 
ceremonies and funerals (Bishop, 2013). Likewise, in Fiji (Vilsoni, 1993), Micronesia (Primo, 
1993), Samoa (Taotua, 1993), the Solomon Islands (Liloqula, Saelea, & Levela, 1993), Tonga 
(Pole, 1993), and several other countries in the South Pacific (Sivan & Liyanage, 1993), taro is 
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considered superior to other root crops and is also the favored commodity for royalty, gift-
giving, feasting, and social obligations. Overall, many Pacific cultures have integrated taro into 
folklore, myths, and legends (Deo et al., 2009), and taro itself is often the core to the cultural 
identity of those cultures (Onwueme, 1999). This proves that the socio-economic role of taro 
across the PICs is unmatched by other root crops, and that role will continue to persist for further 
generations. 
 
3.0 Known Pests and Diseases of Taro 
3.1 Pests 
 Throughout much of the South Pacific, the taro beetle, Papuana spp. (family 
Scarabaeidae, order Coleoptera), is arguably the most important pest of taro, which has been 
documented to cause critical damage to the corm. The size of these shiny black beetles can range 
from 15 to 25 mm in the adult stage. As the beetles burrow into the corm, the tunnels that result 
expose inner flesh and allow other pathogens to infect, causing a secondary rotting which plays a 
factor in corm spoilage in the field and post-harvest storage (Lal et al., 2008). While these 
beetles are not present in Hawaii, an accidental introduction via globalized trading routes may 
pose a risk in the foreseeable future, which necessitates quarantine efforts to prevent such an 
event from occurring. 
 The taro root aphid, Patchella reaumuri, has been a concern since its initial discovery in 
1971 on the Big Island and later in 1995 on Oahu, since it is responsible for disrupting dryland 
taro production (though it has not yet produced any problems for wetland taro production). It is 
believed to be a pest that specifically targets taro and a few other closely related plants. Colonies 
of the taro root aphid are typically covered with a white, fine, cotton-like, and waxy substance, 
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though the aphids themselves are yellow-gray. The reproduction of the aphid occurs without 
male fertilization. Between 75% to 100% of losses in taro varieties are attributed to the taro root 
aphid, and drought conditions exacerbate the damage, especially on young plants (Sato et al. 
1997). 
 Some additional pests of concern to taro include the taro planthopper (Tarophagus spp.) 
by causing wilting and death in heavy infestations, hawk-moth (Hippotion celerio) and 
armyworm caterpillars (Spodoptera litura) both by causing defoliation via feeding on leaves, 
spiraling whitefly (Aleurodicus dispersus), the aphid Aphis gossypii and mealybugs. The growth 
of sooty molds promoted by exuded honeydew can interfere with photosynthesis. Spider mites 
(Tetranychus spp.) can cause some yellow-white speckling and premature leaf death (Carmichael 
et al., 2008). Most notably, mealybugs have often been associated with the infection of taro by 
the transmission of the Taro bacilliform virus (TaBV) (Gollifer et al., 1977; Macanawai et al., 
2005). 
 Snails are also pests of taro, with the giant African snail (GAS) reported to be feeding on 
taro leaves across many PICs. Taro does not appear to be the plant that GAS prioritizes feeding 
on, as with low populations, they can be seen feeding on green cabbage instead (Carmichael et 
al., 2008). The apple snails Pomacea canaliculata (in all Hawaiian islands with the exception of 
Molokai and Lanai) and Pila conica (Molokai only) were originally introduced to Hawaii for the 
purpose of the Hawaiian aquaculture industry but escaped and pose a major threat to taro by 
causing significant damage to the foliage of taro, playing a role in reduced yield in leaves and 
corm (Levin, 2006; Martin, 2004), and can even cause injury or annoyance to workers 





 From the Solomon Islands in 1983 came a report of a nematode Hirschmanniella 
miticausa which caused a unique “miti miti” disease (Bridge, Mortimer, & Jackson, 1983), 
though it can also be found in PNG. Dry, brown rot of the corm about the size of 1 to 10 mm can 
result from an infestation of this nematode. Chlorosis and wilting of the leaves may be indicators 
of infestation, but it is difficult to ascertain that infestation is the cause until corms are harvested 
(Carmichael et al., 2008). Other nematodes that affect taro include root knot nematodes 
(Meloidogyne spp.), which, like their namesake, can cause root knots and decay; and lesion 
nematodes (Pratylenchus coffeae) can cause stunting and death. Yield loss of corms due to 
nematodes has been documented (Arakaki, 1993; Sipes & Arakaki, 1997; Torigoe, Fukunaga, & 
Muta, 2002). 
 
3.3 Fungal Diseases 
 The soil-borne fungus Athelia rolfsii is responsible for the most common fungal disease 
of taro in the Pacific, characterized by the rotting of the taro corm, and in some cases, a pinkish 
rot that occurs post-harvest. Neojohnstonia colocasiae, causing orange leaf spot, and 
Cladosporium colocasiae, causing brown leaf spot, are also common throughout the PICs. 
Lasiodiplodia theobromae, causing spongy black rot, has been found infecting taro in Guam, 
PNG, Samoa, and the Solomon Islands. Leptosphaerulina trifolii, causing white spot disease of 
taro, has been found infecting taro in American Samoa, PNG, Samoa, Solomon Islands, and 
Tuvalu. The fungi causing spongy black rot and white spot diseases of taro have also been 
positively identified in other hosts in the Pacific. Marasmiellus stenophyllus, causing corm and 
leaf spot in taro, has been identified in American Samoa, Tahiti, Wallis, and Futuna, though 
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another host was found with that fungus in Fiji. Other notable fungal pathogens of taro in the 
Pacific include Ceratocystis fimbriata (causing black rot), Fusarium spp. (causing fusarium dry 
rot), Phoma spp. (causing symptoms of “shot hole”), Phyllosticta colocasiophila (causing 
phyllosticta leaf spot), Pseudocercospora colocasiae (causing leaf blotch), and Rhizopus 
stolonifera (causing rhizopus rot) (Carmichael et al., 2008; Ooka, 1990; Parris, 1941). 
 
3.4 Oomycete Diseases 
 Taro leaf blight (TLB) is a very important disease in the history of taro, which caused a 
range of corm yield losses from 25% to 50% in the Pacific and 25% to 35% in the Philippines. 
This disease is triggered by Phytophthora colocasiae and was first reported in Java, Indonesia in 
1900 by Marian Raciborski. The most common site of infection is the leaves, though the petioles 
and corms may also be affected. Infection can also cause losses of up to 95% of leaf yield in 
susceptible taro in Hawaii (Brooks, 2005; Nelson, Brooks, & Teves, 2011). Later epidemics were 
believed to have been in 1918 in Guam, to the first report of TLB in 1920 in Hawaii (Hunter, 
Pouono, & Semisi, 1998). 
An outbreak of TLB in 1993-1994 caused critical damage to the Samoan and American 
Samoan taro industries. The severity of the damage can be noted in profits in the Samoan market 
made after the outbreaks, which was reduced heavily from their usual profits of 10 million USD 
annually to as little as 60 thousand USD, a mere 0.6% of what was earned before. Additionally, 
an annual yield of approximately 400,000 kg in American Samoa before the outbreak was 
reduced to 5,000 kg in 1995, about 1.25% of the typical annual yield (Brooks, 2008; Singh et al., 
2012). Recently, TLB occurs in many places globally, including much of the Pacific, Asia, 
Africa, the Caribbean and the Americas (Nelson et al., 2011) 
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 Pythium rot is another disease caused by oomycetes in the genus Pythium, which was 
first reported by Sedgwick in Hawaii in 1902. Rotting may start from a part of the corm and 
spread upward to infect the whole of the tuber, and the color of the rotting tissue is highly 
variable, including whitish-yellow, gray, blue or purple (Parris, 1941). The appearance of the 
aboveground parts of the plant can make it seem as though it were stunted while dying away 
(Carmichael et al., 2008). Some Pythium species have been found in Hawaii, New Caledonia, 
Palau, Samoa, and the Solomon Islands, and infections can cause losses of up to 80%. 
 
3.5 Bacterial Diseases 
 Erwinia chrysanthemi infection has been reported in the Solomon Islands, leading to 
bacterial soft rot which is characterized by an aqueous soft rotting that is whitish to dark blue and 
a pungent odor (Carmichael et al., 2008). Infection by Xanthomonas axonopodis pv 
dieffenbachiae has also been observed in Hawaii, causing bacterial leaf spot, though the 
symptoms are not severe in taro (Ooka, 1990). 
 
3.6 Viral Diseases 
 Many viral diseases of taro are important, and one such viral disease is “alomae,” noted 
to be a critically destructive disease to taro. The prevalence of this disease is limited to the 
Solomon Islands and PNG, and plants affected by the disease develop symptoms of a feathery 
mosaic, crinkled emerging leaves that do not open, stunting with twisted, dark green leaves; in 
some cases, this causes plant death and consequently causes significant yield losses (Gollifer et 
al., 1978). The causative agent of this disease is believed to be a co-infection of Colocasia 
bobone disease-associated cytorhabdovirus (CBDaV) and Taro bacilliform virus (TaBV) 
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(James, Kenten, & Woods, 1973; Ooka, 1990), though it has been speculated that Taro vein 
chlorosis nucleorhabdovirus (TaVCV) may also play a role in the onset of the disease 
(Carmichael et al., 2008). The delphacid Tarophagus proserpina is a pest associated with the 
transmission of CBDaV, while the mealybugs Planococcus citri and Pseudococcus longispinus 
are associated with the transmission of TaBV (Gollifer et al., 1977; Macanawai et al., 2005). 
 CBDaV is destructive even when it doesn’t co-infect taro together with TaBV, and is a 
putative rhabdovirus that is, like alomae disease, limited to the Solomon Islands and PNG. By 
itself, it causes the bobone disease, which is characterized by symptoms of severe stunting and 
leaves that are distorted, stiff, and thickened, and in some cases, galls may emerge on the petioles 
and larger leaf veins. CBDaV is speculated by some researchers to be the common factor in both 
alomae and bobone diseases and is therefore believed to be the causative agent that contributes to 
the Alomae/Bobone virus complex (ABVC) (Ivancic et al., 1993). The full genomic sequence of 
CBDaV (sampled from taro in the Solomon Islands affected by the bobone disease) was 
published as a 12,193 base pair (bp) negative single-stranded RNA viral genome, with a 
phylogenetic analysis placing it as a putative member of the Cytorhabdovirus genus (Higgins et 
al., 2016a, 2016b). A virus with milder effects, though with the most expansive prevalence 
across the Pacific, is Dasheen mosaic virus (DsMV), a member of the Potyvirus genus. Infection 
by DsMV causes mild to moderate distortions with an array of mosaic patterns, and, as a stylet-
borne and nonpersistent virus, is caused by transmission via aphids, including Aphis craccivora, 
A. gossypii, and Myzus persicae (Ooka, 1990). 
 TaBV (genus Badnavirus) also has a widespread prevalence across the Pacific, initially 
reported by James et al. (1973) and sequenced about 30 years later (Yang et al., 2003). 
Symptoms of TaBV include latent and erratic yellowing of the veins, proximal to the margin of 
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the leaf, as well as creasing or bending of the leaf blades (Carmichael et al., 2008). A recent 
attempt to perform deep sequencing of small RNAs (sRNAs) from a sample of taro plants 
(displaying symptoms that resembled those of a plant infected with TaBV) yielded the discovery 
of another virus within the genus Badnavirus, tentatively named Taro bacilliform CH virus 
(TaBCHV) (Kazmi et al., 2015). 
 An important yet understudied viral pathogen of taro is Taro vein chlorosis 
nucleorhabdovirus (TaVCV), which was first reported in 1999 by Pearson et al. and later fully 
sequenced by Revill et al. in 2005 using a Fijian isolate, which allowed it to be officially 
recognized as a member of the genus Nucleorhabdovirus. Reports of TaVCV to date have 
confirmed that TaVCV-infected taro in nine countries in the Pacific, namely Fiji, the Federated 
States of Micronesia, New Caledonia, Palau, PNG, the Solomon Islands, Tuvalu, Vanuatu, and a 
recent discovery was made in Hawaii as a part of the United States of America (Long et al., 
2014). A feather-like chlorotic symptom can be seen on leaves of infected taro, which gradually 
broadens with age and eventually fuses into a network with the possibility of necrosis in later 
stages. Chlorosis is more evident in TaVCV infections compared to TaBV infections. Additional 
symptoms include petiole streaking and stunting, and, in severe cases, plant death. 
 Another virus of taro is Taro reovirus (TaRV), found in PNG, the Solomon Islands, and 
Vanuatu, though its effects on taro are currently unclear (Revill et al., 2005). In India, an isolated 
case of Groundnut bud necrosis virus (GBDV) infecting taro was reported, causing symptoms of 
chlorotic spotting, mosaic patterns, necrotic flecking on leaves, and overall stunting (Sivaprasad 
et al., 2011). Cucumber mosaic virus (CMV) has also been reported in taro plants in China 
(Wang et al., 2014), and Konjac mosaic virus (KoMV) has been found to infect three aroid 




4.0 Taro vein chlorosis nucleorhabdovirus (TaVCV) (genus Nucleorhabdovirus, family 
Rhabdoviridae, order Mononegavirales) 
4.1 Family Rhabdoviridae 
 The order Mononegavirales, established in 1991 (Pringle, 1991), encompasses many viral 
families that contain members that are monopartite, single-stranded, negative-sense RNA 
viruses. One of the families that are included in that order is the Rhabdoviridae family, which 
contains 20 assigned genera, including Cytorhabdovirus (with 11 species), Dichoravirus (with 5 
species), and Nucleorhabdovirus (with 10 species), along with one unassigned species that has 
not yet been assigned to a genus (“International Committee on Taxonomy of Viruses,” 2019). 
Members of families belonging to this order are often separated based on their hosts, the vector 
of transmission, as well as serological assays and properties of the viral genome (Jackson et al., 
2005). From the 20 genera in the family, only three (Cytorhabdovirus, Dichoravirus, 
Nucleorhabdovirus) contain members that have been documented to infect plants (Walker et al., 
2000). Typical morphological features of Rhabdoviridae family members include enveloped 
virions with a bacilliform shape, ranging from a width of 45 to 100 nm to a length of 130 to 350 
nm (Brown, 1987), though members of the genus Dichoravirus are exceptions, with unenveloped 
particles and bipartite genomes (Kondo et al., 2006). 
 The organization of a rhabdovirus, from the 3’-end to 5’-end (in negative polarity), is the 
leader sequence; the open reading frames (ORFs) coding for nucleoprotein (N), phosphoprotein 
(P), matrix protein (M), glycoprotein (G), RNA-dependent RNA polymerase (RdRp, or L); then 
trailer sequence. The nucleoprotein (N) is a protein that makes up a significant portion of the 
nucleocapsid, part of the virion. The phosphoprotein (P) is a regulatory protein and non-catalytic 
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cofactor of the RdRp coded downstream. The matrix (M) protein is a structural component of the 
rhabdovirus virion and is usually involved in interactions with cellular membranes and the 
budding process. The glycoprotein (G) aids in binding to surface receptors on host cells, causing 
the virus to be taken into the cell. Lastly, the RdRp (L) is the polymerase responsible for 
replication of the viral RNA genome. Though these five genes are common features of all 
rhabdoviruses, those that have been fully sequenced may carry up to four additional ORFs, 
positioned between either the P and M ORFs or the G and L ORFs (Healy, Banyard, & Fooks, 
2013; “International Committee on Taxonomy of Viruses,” 2019; Jackson et al., 1987; 
Redinbaugh & Hogenhout, 2005; Walker et al., 2000, 2015). 
 
4.2 Genus Nucleorhabdovirus 
 The genus Nucleorhabdovirus is one of the three viral genera that have plant hosts in 
family Rhabdoviridae. The morphology of the virion is typically either bacilliform or bullet-
shaped, with dimensions of 170 to 380 nm in length and 55 to 100 nm in diameter, encapsulating 
an unsegmented negative-sense single-stranded (ss)RNA genome (Fig. 1.1). The virion is 
arranged in a symmetrical helix, with glycoproteins spread across the surface, and its 
composition is roughly 1% nucleic acid, 70% protein, and 25% lipid (Adams & Antoniw, n.d.). 
Once the virus has entered the cell via effraction or plasmodesmata transport, the virus is moved 
to the nucleus of the host cell, where its replication and maturation site is located. 
Nucleorhabdovirus, as per most genera of the family Rhabdoviridae, typically have 
monopartite, linear, and negative-sense ssRNA genomes 11 to 15 kb in length (Brunt et al., 
1996). The type member of the genus Nucleorhabdovirus is Potato yellow dwarf 
nucleorhabdovirus (PYDV), and other members include Sonchus yellow net nucleorhabdovirus 
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(SYNV), Rice yellow stunt nucleorhabdovirus (RYSV), Sowthistle yellow vein 
nucleorhabdovirus (SYVV), Eggplant mottled dwarf nucleorhabdovirus (EMDV), Maize fine 
streak nucleorhabdovirus (MFSV), Maize mosaic nucleorhabdovirus (MMV), Maize Iranian 
mosaic nucleorhabdovirus (MIMV), and Taro vein chlorosis nucleorhabdovirus (TaVCV) 
(“International Committee on Taxonomy of Viruses,” 2019). The genome organization of most 
members of the genus Nucleorhabdovirus follows the family Rhabdoviridae in that there are N, 
P, M, G, and L ORFs, but this genus contains members that contain an additional ORF, gene 3, 
between the P and M ORFs (Fig 1.2). The function of this gene 3 ORF is currently unclear. 
 
 
Fig. 1.1. Diagram of the putative Nucleorhabdovirus structure. 





Fig. 1.2. Genomic arrangement of typical members of the genus Nucleorhabdovirus, including 
Taro vein chlorosis nucleorhabdovirus. The following ORFs in coding orientation are 
nucleoprotein (N), phosphoprotein (P), gene 3, matrix protein (M), glycoprotein (G), RNA-
dependent RNA polymerase (L). Based on: http://viralzone.expasy.org/all_by_species/78.html 
 
4.3 Known Distribution and History of TaVCV 
 TaVCV has been reported across several countries in the South Pacific, including the 
Federated States of Micronesia, Fiji, New Caledonia, Palau, PNG, the Solomon Islands, Tuvalu, 
Vanuatu (Carmichael et al., 2008), and recently in Hawaii. The earliest reports of TaVCV 
originated from Fiji, PNG, Tuvalu, and Vanuatu. The original demarcation of TaVCV was done 
by comparison of the viral morphology (in terms of particle size), symptoms, and serological 
activity to distinguish TaVCV from CBDaV (Pearson et al., 1999). The effects of the virus on 
taro resulted in the nomenclature of “Taro vein chlorosis virus.” 
 A viral survey done in 2002 by inspection of taro plants in Fiji found that TaVCV was 
widespread based on a visual inspection of symptoms alone (Harding, Williams, & Jackson, 
2002). The purpose of this survey was to collect taro leaf tissues from symptomatic plants to 
purify and index the virus. The publication by Revill et al. (2005a) was the first publication 
detailing the complete sequence (and electron microscopy) of TaVCV, which was sampled from 
an isolate in Fiji, and allowed TaVCV to be officially recognized as a member of the genus 
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Nucleorhabdovirus. The basis of this recognition was the six ORFs which were analogous to the 
six ORFs (N, P, 3, M, G, L) found in other members of the genus. 
 Another element of their publication claimed that high nucleotide diversity existed 
between TaVCV isolates from Fiji, the Federated States of Micronesia, New Caledonia, PNG, 
the Solomon Islands, and Vanuatu. They also showed that the most closely related species was 
Maize mosaic virus (MMV), another member of the Nucleorhabdovirus genus. The identity of 
each of the ORFs with MMV were: 63.1% (N), 46.1% (P), 43.4% (gene 3), 46.4% (M), 49.9% 
(G), and 67.9% (L). A phylogenetic analysis using the L gene grouped TaVCV in a clade with 
other Nucleorhabdovirus members, apart from other clades in the family Rhabdoviridae. 
 
4.4 The Symptomatology of TaVCV 
 Symptoms related to TaVCV typically emerge when a taro plant has matured. These 
symptoms include a yellowing of the leaf veins, close to the margin, gradually spreading through 
the leaf into a network. This chlorotic effect is often more visibly pronounced than in the 
chlorosis produced by TaBV infection. Necrosis may be seen in the later stages of viral infection, 
and the leaves may appear tattered or bent downward. Only a few leaves can appear diseased 
while other leaves appear healthy (Carmichael et al., 2008). Depending on the cultivar, taro may 
exhibit petiole streaking and stunting (Fig. 1.3a-g). Currently, it is unknown if TaVCV affects 
corm yield. Visual examination may suffice for a preliminary diagnosis of TaVCV, but the 
emergence of symptoms can vary between varieties and cultivars of taro, so further analysis 




Fig. 1.3. Visual foliar symptoms of TaVCV in increasing severity from left to right (a); other 
symptoms that can be seen include petiole streaking (b), stunting (c), downward bending (d, e), 
veinal chlorosis (f), and necrosis (g). Adopted from 
https://www.ctahr.hawaii.edu/oc/freepubs/pdf/PD-111.pdf 
 
4.5 Description of TaVCV 
4.5.1 Particle Morphology 
 The electron microscopy data submitted by Revill et al. (2005a) confirms TaVCV to be 




Fig. 1.4. Electron micrographs depicting cross-sections of a cell infected with TaVCV (a), 
focusing on the nucleus (N) of the cell, containing TaVCV virions (V). At the nuclear envelope 
seen more closely in the boxed area (b), the perinuclear space, between the inner membrane (M) 
and outer membrane (E), contains virions. Bar: 200 nm. Adopted from Revill et al. (2005a). 
 
4.5.2 Genome Organization 
 The Fijian isolate of the negative-sense ssRNA genome of TaVCV (GenBank accession 
number NC_006942.1) is 12,020 base pairs (bp) in length, coding for six major ORFs. These 
ORFs are organized similarly to other Nucleorhabdovirus genus members, which is, in coding 
orientation, N, P, gene 3, M, G, L. The length of each gene in this isolate is 1506 (N), 813 (P), 
861 (3), 705 (M), 1764 (G) and 5784 (L) nucleotides (Revill et al., 2005a). Though the function 
of the gene 3 protein has yet to be confirmed, it has been shown to serve as a putative movement 
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protein (MP) in RYSV (Huang et al., 2005) as well as SYNV, though gene 3 is referred to as the 
sc4 gene (Goodin et al., 2002; Scholthof et al., 1994). 
 
4.5.3 Transmission 
 The vector of transmission for TaVCV has not yet been determined; however, it is useful 
to discuss possible modes of transmission by an analysis of transmission for other closely related 
viruses. It has been found that planthoppers are the vectors of transmission for other 
Nucleorhabdovirus genus members such as MMV via the corn planthopper Peregrinus maidis 
and MIMV via the planthopper Ribautodelphax notabilis (ICTV, online). Notably, CBDaV (a 
Cytorhabdovirus) is transmitted through Tarophagus proserpina, the taro planthopper (Gollifer 
et al., 1977). 
Leafhoppers are also associated with the transmission of other Nucleorhabdovirus 
members, such as EMDV via the Agallinae leafhoppers Anaceratogallia laevis, A. ribauti and 
Agallia vorobjevi (Babaie & Izadpanah, 2003), MFSV via the blackfaced leafhopper Graminella 
nigrifrons (Redinbaugh et al., 2002; Todd et al., 2010), PYDV via the clover leafhopper 
Aceratagallia sanguinolenta (Black, 1943), and RYSV via the green rice leafhoppers Nephotettix 
nigropictus, N. cincticeps, and N. virescens (Chiu et al., 1965; Hiraguri et al., 2014). 
Only two of the Nucleorhabdovirus members are transmitted through aphids: SYNV via 
Aphis coreopsidis (Christie, Christie, & Edwardson, 1974) and SYVV via the blackcurrant-
sowthistle aphid Hyperomyzus lactucae (Duffus, 1963; Richardson & Sylvester, 1968) and, to a 
lesser degree of efficiency, the potato aphid Macrosiphum euphorbiae (Behncken, 1973). 
TaVCV has been spread with the use of contaminated planting material (Long et al., 
2014). Considering the transmission modes currently determined for the members of the genus 
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Nucleorhabdovirus, there is a high likelihood that a planthopper or leafhopper is the vector for 
TaVCV transmission. The insects that interact with taro are the taro planthoppers, Tarophagus 
colocasiae, T. persephone, and T. proserpina, which are each distributed in varying degrees 





















CHAPTER 2: GENOMIC ANALYSES OF PACIFIC TARO VEIN CHLOROSIS 
NUCLEORHABDOVIRUS (TAVCV) ISOLATES 
Introduction 
 Many viral genomes are small compared to prokaryotic and eukaryotic genomes, with the 
latter often consisting of several megabases of genomic DNA. Additionally, prokaryotic and 
eukaryotic genomes encode DNA polymerases that have proofreading ability and thus minimize 
the probability of random mutations that can result when duplicating their genomes, while 
viruses often code for polymerases that lack proofreading ability. As a result, despite the small 
size of many viral genomes, viruses often evolve at a much faster rate due to a higher incidence 
of random mutations, contributing to their survival and adaptability when infecting hosts. The 
same concept applies to many viruses. 
 The study by Revill et al. reported a widespread prevalence of TaVCV across several 
different countries across the South Pacific (2005). This prevalence, combined with the concept 
of error-prone replication, could eventually yield a high genetic diversity of TaVCV among 
regional isolates. Therefore, a study utilizing next-generation sequencing to elucidate the full 
genomes of TaVCV, especially the protein-coding sequences, may help to shed light on a 
possible pathway through which the virus had spread historically, as well as to contribute 
genomic data of TaVCV isolates, which has not been further explored since the first submission 
of a Fijian TaVCV isolate in part of Revill’s study. 
 The Nucleorhabdovirus genus is unique compared to other genera in the Rhabdoviridae 
family in that it contains members that can replicate and assemble in the nucleus, while the other 
genera contain members that replicate and assemble in the cytoplasm. Some proteins contain 
domains that interact with the nucleus, allowing migration to and from the nucleus. These 
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domains are the nuclear localization signals (NLSs) and nuclear export signals (NESs). A typical 
NLS consists of lysine and arginine amino acids, while a typical NES consists of leucine-rich 
segments that are usually hydrophobic. The cNLS Mapper (Kosugi et al., 2009) and NetNES 1.1 
(la Cour et al., 2004) programs can detect NLSs or NESs, respectively, based on literature 
describing proteins with such motifs. cNLS Mapper scores detected NLSs, and a score of 8 
through 10 suggests the protein is exclusively localized to the nucleus, while a lower score of 3 
through 5 suggests the protein is distributed between the nucleus and cytoplasm. A score below 3 
suggests exclusively cytoplasmic distribution and is therefore implied to not interact with the 
nucleus. NetNES 1.1 uses a score system which needs to meet a threshold to detect the presence 
of NESs in proteins of interest. While Revill’s study was able to provide electron microscopy 
data, it would be useful to look at other isolates for these traits as some proteins from different 
isolates may have some differences in their sequences worth investigating. Additionally, the 
original publication does not reference the use of cNLS Mapper and NetNES 1.1, the latter of 
which was unavailable at the time of publication. 
 
Materials and Methods 
Sample Source 
 The Hawaii sample was collected on November 2017 at Waimanalo Research Station 
(21.335678, -157.712063). The Guam samples were collected on June 2018 by Nelson Masang, 
Jr. at Hagatña, Guam (approx. 13.471291, 144.760277) and imported under USDA-APHIS 
permit P526P-16-03581. The Palau samples were collected on June 2018 by Nelson Masang, Jr. 
at Koror, Palau (approx. 7.350186, 134.495277) and imported under USDA-APHIS permit 
P526P-17-03915. The Samoa samples were collected on November 2017 by the Ministry of 
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Agriculture and Fisheries Samoa and imported under USDA-APHIS permit P526P-17-03915. 
The variety of the Samoan sample was ‘Talo mumu’. The Vanuatu samples were collected on 
March 2019 at the Vanuatu Agricultural Research & Technology Centre, Espiritu Santo (-
15.451257, 167.189511) and imported under USDA-APHIS permit P526P-17-03915. 
All Fiji samples came from Viti Levu island. The Navua samples came from the fields 
located between Pacific Harbour and Navua town (approx. -18.226804, 178.132221). The Nais 
sample came from the roadside between Wainisikia and Naimasimasi villages (approx. -
17.922106, 178.556247). The Nadi samples came from a residential garden near the airport (-
17.743295, 177.450381). All were collected in March 2019 and imported under USDA-APHIS 
permit P526P-17-03915. 
All samples were suspended in RNAlater and subsequently stored at -20 °C upon arrival 





Fig. 2.1. Pacific-centric map featuring the sampling locations circled with a purple outline, 
except for Hawaii. 
 
Detection of TaVCV 
 RNA was extracted from taro leaves using the plant RNA isolation protocol for the 
NucleoSpin RNA Plus kit. The reverse transcription polymerase chain reaction (RT-PCR) was 
performed using SuperScript III One-Step RT-PCR System as follows. 1 µL RNA, 1 µL 10 µM 
DCGF3 (5’-GTCTGGTAAAGAGGGGTTGA-3’), 1 µL 10 µM DCGR3 (5’-
GTCGAGGGTCATGATAGAGT-3’), 6.2 µL nuclease-free H2O were mixed, incubated at 95 °C 
for 8-10 min, then immediately chilled on ice for at least 1 min and centrifuged. To this reaction, 
10 µL 2x Reaction Mix and 0.8 µL SuperScript III RT/Platinum Taq Mix were added. The 
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reaction was then incubated at 55 °C for 30 min, then 94 °C for 2 min, followed by 40 cycles of 
94 °C for 15 sec, 55 °C for 30 sec, 68 °C for 1 min, then 68 °C for 5 min. This procedure was 
repeated for DCGF5 (5’-AGGGGYTGAGRCAAAAGGGGT-3’) and DCGR5 (5’-
CGCTCYTTCATACATGCSGCCTT-3’) primers, replacing DCGF3 and DCGR3. These 
reactions were run on an agarose gel and a band corresponding to the expected size was cut from 
the gel, extracted by a centrifugation step through filter paper at maximum speed (21,130 g) for 2 
min. 
 0.3 µL of pGEM T-Easy vector, 3.7 µL gel eluate, 5 µL 2x Rapid Ligation Buffer and 1 
µL T4 DNA Ligase (3 U/µL) were mixed and incubated overnight at RT. The following day, a 
tube containing chemically competent E. coli DH5α cells was thawed on ice for 10 min, then 2-5 
µL of the ligation reaction was added to the tube of cells, flicked gently 4-6 times and incubated 
on ice for 60 min. The tube was then added to a water bath at exactly 42 °C and incubated for 30-
45 sec before immediately placing the tubes back on ice for 2 min. Super Optimal Broth (450 
µL) was then added to the tube and incubated at 37 °C for 45 min with shaking (200-300 rpm). 
250 µL was then plated on MacConkey Agar containing ampicillin antibiotics at a concentration 
of at least 100 µg/mL, then incubated overnight at 37 °C. 
Bacteria colony PCR using T7 and SP6 primers was then performed for each white 
colony that grew on the agar, and colonies that amplified products at roughly the expected size 
were then grown in Luria-Bertani medium (LB) containing ampicillin at a concentration of at 
least 100 µg/mL overnight. The QIAgen Spin Miniprep Kit was used to purify the plasmid 
containing the insert of interest and the plasmid that was eluted from the kit was then sequenced. 
 
Double-Stranded (ds)RNA Extraction (Large-Scale) 
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 The following method is based on the plant viral double-stranded RNA (dsRNA) protocol 
by Morris and Dodds (1979), Bar-Joseph et al. (1983) and Dodds et al. (1984). About 5 g of 
symptomatic leaf tissue from Hawaii or Samoa was ground into a powder in liquid nitrogen 
using a mortar and pestle, which was pre-cooled overnight in a -20 °C freezer. The powdered 
leaf tissue was then added to 200 mL of dsRNA extraction buffer (10X STE 18 mL, 10% SDS 
30 mL, β-Mercaptoethanol 2 mL, dH2O 72 mL, saturated phenol 40 mL, chloroform 40 mL; 10X 
STE = Tris-HCl 61.0 g, NaCl 58.0 g, EDTA 3.7 g, dH2O to 1000 mL, pH 8.0), then stirred with a 
magnetic stir bar for 45-60 minutes at 4 °C. The solution was then transferred to a 250 mL bottle 
and centrifuged at 8,000 rpm for 10 minutes. The aqueous phase was transferred to a new bottle, 
then 0.2 volumes (with respect to the aqueous phase volume) of EtOH was added. 2 g of CF-11 
cellulose powder was added to the solution, which was then gently shaken on an orbital shaker 
for 30 minutes at room temperature (RT). This solution with cellulose powder was added to a 
column and the liquid was allowed to flow through, then the column was washed with at least 
100 mL of 1X STE containing 16.5% (v/v) EtOH. The liquid was then purged from the cellulose 
and the dsRNA was then eluted into a 50 mL centrifuge tube with three 10 mL aliquots of 1X 
STE, each of which was purged after each elution. 6 mL EtOH (0.2 volumes with respect to 
elution volume), then 1.5 g of CF-11 cellulose powder was added to the eluate and gently shaken 
on an orbital shaker overnight at RT. The solution with powder was then added to a column, the 
liquid was allowed to flow through and the column was then washed with at least 100 mL of 1X 
STE containing 16.5% (v/v) EtOH. The liquid was then purged from the cellulose, and the 
dsRNA was then eluted into a 15 mL centrifuge tube with three aliquots of 3 mL 1X STE, each 
of which was purged after each elution. The tubes were then spun in a centrifuge for 1 minute to 
pellet the cellulose, and the supernatant was then transferred to a 30 mL Corex centrifuge tube. 
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0.9 mL of 3 M sodium acetate (pH 5.2) was then added to the transferred solution, and the tube 
was filled as close to the top as possible with 95% EtOH (about 20 mL). The tube was sealed 
with Parafilm, inverted to mix the solution well and incubated overnight at -20 °C. 
 The next day, the tubes were centrifuged at 12,000 rpm for 30 minutes. The supernatant 
was then decanted, and the pellet was then resuspended in 500 µL of molecular-grade (nuclease-
free) water. The dsRNA solution was then concentrated using an Amicon Ultra centrifugal filter 
(50 kDa molecular weight cutoff). 
 
Double-Stranded (ds)RNA Extraction (Small-Scale) 
 About 100 mg of symptomatic leaf sample from Guam, Palau and Vanuatu was 
homogenized in 1 mL CTAB extraction buffer (CTAB 10 g, PVP-40 10 g, 1 M Tris-Cl (pH 8) 50 
mL, NaCl 41 g, 0.5 M EDTA (pH 8) 20 mL, 2-mercaptoethanol 2 mL, dH2O to 500 mL) using a 
mortar and pestle after cooling in -20 °C for 5-15 min. The homogenized sample was then 
incubated at 65 °C for 15 min, followed by centrifugation at 10,000 g for 5 min. Up to 1 mL of 
supernatant was transferred to another clean microcentrifuge tube, then an equal volume of 
chloroform:isoamyl alcohol (24:1) solution was added to the supernatant, then mixed by 
vortexing before centrifuging at 5,000 g for 5 min. The aqueous upper phase was transferred to 
another clean microcentrifuge tube, and a volume of isopropanol equal to the volume of the 
aqueous phase was added, mixed gently, then incubated at room temperature for 5 min before 
centrifuging at 15,000 for 10 min. The supernatant was poured off and the pelleted nucleic acids 
left to dry at room temperature. The pellet was then resuspended in 100 µL of DNase/RNase-free 
dH2O. About 20 µL of 95% EtOH was added to the solution, then about 40 mg of CF-11 
cellulose powder was added, followed by incubation at 30 min at RT with gentle shaking in an 
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orbital shaker. The suspension was added to a makeshift spin column made from a 0.6-mL 
microcentrifuge tube with a small opening on the bottom and a small piece of filter paper made 
to prevent the passage of solid material. This was centrifuged in a 1.5-mL microcentrifuge tube 
at 1,000 g for 2 min to let the liquid flow through. The powder left in the column was washed at 
least three times with 250 µL aliquots of 1X STE containing 16.5% (v/v) EtOH. The liquid was 
then purged from the cellulose, and the dsRNA was eluted with three 100 µL aliquots of 1X 
STE, each of which was purged after elution. The eluate was centrifuged for 1 min to pellet any 
cellulose that may have passed through the filter, and the supernatant was transferred to an 
Amicon Ultra centrifugal filter (50 kDa molecular weight cutoff) to concentrate nucleic acids. 
 
Preparation of cDNA Library for Next-Generation Sequencing 
 The dsRNA eluate was used as a template for reverse transcription. 1 µL dsRNA, 1 µL 
10 µM Up-dN6 primer (5’-GCCGGAGCTCTGCAGAATTCNNNNNN-3’), 10 µL nuclease-free 
H2O were mixed, incubated at 95 °C for 8-10 min, then immediately chilled on ice for at least 1 
min and spun down by centrifugation. To this reaction, 4 µL 5x First-Strand Buffer, 2 µL 0.1 M 
dithiothreitol, 1 µL (40 U/µL) rRNAsin Ribonuclease Inhibitor and 1 µL SuperScript III Reverse 
Transcriptase (200 U/µL) were added. The reaction was incubated at 25 °C for 5-10 min, then 50 
°C for 60 min, then inactivated by incubating at 98 °C for 2 min, followed by chilling on ice and 
a brief centrifugation step. 0.5 µL RNAse H (1.5 U/µL) was added and incubated at 37 °C for 30 
min. 480 µL of nuclease-free water was then added to the reaction and purified and concentrated 
using an Amicon Ultra centrifugal filter (50 kDa molecular weight cutoff). 
 The eluate was mixed with an equal volume of 2x GoTaq Green Master Mix and 
incubated in a thermocycler with the following cycling conditions: 95 °C for 7 min, then 10 
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cycles of 95 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min, followed by 72 °C for 7 min. 1 
µL of the previous reaction, 2 µL 10 µM Up primer (5’-GCCGGAGCTCTGCAGAATTC-3’), 7 
µL nuclease-free H2O, 10 µL 2x GoTaq Green Master Mix were mixed and incubated in a 
thermocycler with the following cycling conditions: 95 °C for 7 min, then 35 cycles of 95 °C for 
1 min, 55 °C for 1 min and 72 °C for 1 min, followed by 72 °C for 7 min. This reaction was then 
purified using an Amicon Ultra centrifugal filter (50 kDa molecular weight cutoff). Polymerase 
chain reaction (PCR) products which ranged from 300-1000 base pairs (bp) of length were then 
sequenced on the MiSeq platform for high-throughput sequencing. Sequencing data was then 
used to construct the genomes of viral sequences with the help of Galaxy version 19.05 and 
Geneious version 10.2.6. 
 
Rapid Amplification of cDNA Ends (RACE) 
 Primers were designed based on the tentatively assembled viral genomes such that the 
terminal sequences can be generated by reverse transcription. 
In a sterile microcentrifuge tube, 1 µL dsRNA, 1 µL 10 µM NeoTaVCV_N primer (5’-
CTCGGGATTTCACCTGCCTT-3’) or NeoTaVCV_C primer (5’-
CATTGGAGGAAGGGCTGTCA-3’) for 5’-RACE or 3’-RACE respectively, 10 µL nuclease-
free H2O were mixed, incubated at 95 °C for 8-10 min, then immediately chilled on ice for at 
least 1 min and spun down by centrifugation. To this reaction, 4 µL 5x First-Strand Buffer, 2 µL 
0.1 M dithiothreitol, 1 µL (40 U/µL) rRNAsin Ribonuclease Inhibitor and 1 µL SuperScript III 
Reverse Transcriptase (200 U/µL) were added. The reaction was incubated at 50 °C for 60 min, 
then inactivated by incubating at 98 °C for 2 min, followed by chilling on ice and a brief 
centrifugation step, which was then purified by the QIAgen PCR Purification Kit. 
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 The eluate was then used as a template for terminal deoxynucleotidyl transferase (TdT) 
tailing. 10 µL of the eluate containing cDNA, 5 µL 5x TdT buffer, 1.25 µL 100 µM dGTP (for 
5’-RACE) or dATP (for 3’-RACE), 8.25 µL nuclease-free dH2O and 0.5 µL TdT (15 U/µL) were 
mixed and incubated at 37 °C for 30 min, then inactivated by heating to 75 °C for 10 min. This 
reaction was also purified by the QIAgen PCR Purification Kit. 
 1 µL dGTP or dATP-tailed cDNA, 1 µL 10 µM Poly-dC_5_RACE primer for 5’-terminal 
dGTP-tailed cDNA (5’-TTACTAATATCCCCCCCCCCCC-3’) or Poly-dT_3_RACE primer for 
3’-terminal dATP-tailed cDNA (5’-GACCACGCGACGTGTCGAVTTTTTTTTTTTTTTT-3’) 
respectively, 7 µL nuclease-free dH2O, 10 µL 2x GoTaq Green Master Mix was mixed, then 
incubated in a thermocycler at 95 °C for 5 min, then 52 °C (for 5’-terminus) or 37 °C (for 3’-
terminus) for 2 min, then 72 °C for 40 min. 1 µL 10 µM terminal primer that was used for cDNA 
synthesis was then added to the reaction, then the reaction was incubated in a thermocycler for 
30 cycles of 95 °C for 1 min, 60 °C for 1 min, 72 °C for 3 min with a final extension step of 72 
°C for 15 min. Each reaction was diluted at a 1:100 ratio in nuclease-free dH2O for a half-nested 
PCR. This half-nested PCR used another primer designed to anneal further down the terminal 
sequence. 
 1 µL dGTP or dATP-tailed cDNA, 1 µL 10 µM Poly-dC_5_RACE primer for 5’-terminal 
dGTP-tailed cDNA (5’-TTACTAATATCCCCCCCCCCCC-3’) or Poly-dT_3_RACE primer for 
3’-terminal dATP-tailed cDNA (5’-GACCACGCGACGTGTCGAVTTTTTTTTTTTTTTT-3’), 
1 µL 10 µM TaVCV_N primer (5’-GGGATRKTGATGTAYGACAT-3’) or TaVCV_C primer 
(5’-TKCACGAYCTHCTGGA-3’) for 5’-RACE or 3’-RACE respectively, 7 µL nuclease-free 
dH2O, 10 µL 2x GoTaq Green Master Mix was mixed, then incubated in a thermocycler at 95 °C 
for 5 min, then 30 cycles of 95 °C for 1 min, 55 °C for 1 min, 72 °C for 3 min with a final 
37 
 
extension step of 72 °C for 15 min. This reaction was run on an agarose gel and a band 
corresponding to the expected size was cut from the gel, extracted by a centrifugation step 
through filter paper at maximum speed (21,130 g) for 2 min. 
 0.3 µL of pGEM T-Easy vector, 3.7 µL gel eluate, 5 µL 2x Rapid Ligation Buffer and 1 
µL T4 DNA Ligase (3 U/µL) were mixed and incubated overnight at RT. The following day, a 
tube containing chemically competent E. coli DH5α cells was thawed on ice for 10 min, then 2-5 
µL of the ligation reaction was added to the tube of cells, flicked gently 4-6 times and continued 
incubation on ice for 60 min. The tube was then added to a water bath at exactly 42 °C and 
incubated for 30-45 sec before immediately placing the tubes back on the ice for 2 min. 450 µL 
of Super Optimal Broth (SOB) was then added to the tube and incubated at 37 °C for 45 min 
with shaking (200-300 rpm). 250 µL was then plated on MacConkey Agar containing ampicillin 
antibiotics at a concentration of at least 100 µg/mL, then incubated overnight at 37 °C. 
Bacteria colony PCR using T7 and SP6 primers was then performed for each white 
colony that grew on the agar, and colonies that amplified products at roughly the expected size 
were then grown in Luria-Bertani medium (LB) containing ampicillin at a concentration of at 
least 100 µg/mL overnight. The QIAgen Spin Miniprep Kit was used to purify the plasmid 
containing the insert of interest and the plasmid that was eluted from the kit was then sequenced. 
 
Sequence Analysis and Phylogeny 
 MEGA-X (Kumar et al., 2018) was used for protein sequence alignment of L genes using 
the ClustalW algorithm. This alignment was then used for the generation of a phylogram with the 
neighbor-joining and maximum likelihood methods, which were each performed with 1,000 
bootstrap replicates. To analyze the potential nuclear localization signals (NLSs) and nuclear 
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export signals (NESs), cNLS Mapper (cutoff score = 3) (Kosugi et al., 2009) and NetNES 1.1 (la 
Cour et al., 2004) were used for each of the putative protein sequences, respectively. 
 














Table 1. List of primers used in this study. NeoTaVCV_N and NeoTaVCV_C are both primers 
used for the reverse transcription reaction and the first round of PCRs for their respective 
terminal RACE procedure. TaVCV_N and TaVCV_C are both primers used for the half-nested 
PCRs following the first round of PCRs to improve specificity that may have been an issue if 






Results and Discussion 
 The spread of a destructive plant virus is a major concern for crop cultivation. As TaVCV 
is regarded as a taro pathogen with a dire impact on the production of taro by reducing plant 
yield as a result of infection, its regional prevalence across the Pacific is a concern for taro 
cultivation internationally. Though TaVCV was officially acknowledged as a unique virus 
separate from CBDaV due to electron microscopy in 1999 (Pearson et al.), the existence of 
several unique Nucleorhabdovirus species poses the possibility of the virus infecting taro many 
years before its initial report, though it is unclear as to how long TaVCV has been infecting taro. 
Due to its relative isolation in different Pacific Island Countries, the virus has been able to 
propagate and evolve independently of other isolates. As a result, high nucleotide sequence 
diversity among several different isolates of TaVCV has emerged, though this diversity is too 
low to be considered a separate species from the common ancestor of the virus. Nonetheless, 
with better tools readily available for the analysis of these isolates, more information regarding 
the viral sequences as well as putative protein products can be gleaned based on considerations 
of functions that were established in other related species of the Nucleorhabdovirus genus. Thus, 
sampling alternate isolates from different Pacific Island Countries both contributes to the current 
breadth of knowledge regarding both Nucleorhabdovirus species and TaVCV, and provides more 
genomic data of TaVCV, supporting the initial observation of high nucleotide diversity by Revill 
et al. (2005a). 
 All samples except those from Fiji were positive for TaVCV in RT-PCR. Any mention of 
the Fijian isolate in this chapter is based on the GenBank accession number NC_006942.1, the 
submission of the Taro vein chlorosis nucleorhabdovirus genome from Revill et al. (2005a). The 
number of reads obtained from high-throughput sequencing and the number of TaVCV-specific 
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reads are listed together with their respective isolate in Table 2. The complete sequence of the 
Hawaiian TaVCV isolate is 12,037 bp in length with a G/C content of 47.1%, the Samoan 
TaVCV isolate is 12,086 bp in length with a G/C content of 47.7%, the Palauan TaVCV isolate 
is 12,072 bp in length with a G/C content of 46.8%. All isolates (including from Fiji, Guam, and 
Vanuatu) contained six major open reading frames (ORFs) on the same strand. Each of the ORFs 
correspond to the respective protein that is encoded, including the putative proteins for a 
nucleorhabdovirus: nucleocapsid protein (N), phosphoprotein (P), gene 3, matrix protein (M), 
glycoprotein (G) and RNA-dependent RNA polymerase (L). The lengths of the putative amino 
acid products from the six major ORFs are organized together with their respective isolate (Table 
3). The amino acid lengths of gene 3 and G in all isolates are the same, with other genes having 
some level of variability in this aspect. Hawaii and Guam isolates have longer putative N and M 
products with a product size of 487 amino acids and 249 amino acids, respectively, compared to 
the Palau, Samoa, and Vanuatu isolates. The M product is also shorter in the Fiji isolate. Only 
the Palau isolate exhibited a different length for P at 259 amino acids while other isolates had a 
length of 271 amino acids. The N protein varied widely between the isolates, especially for Fiji 
with a length of 502 amino acids.  
A putative polyadenylation site (3’-AAUUCUUUUUGGG-5’ in virion-sense orientation) 
is observed in all isolates in the 3’-leader sequence and downstream of each putative ORF. For 
each polyadenylation site except for the one downstream of the L gene, at least an additional two 
uracils follow immediately after the guanines in the site. This site is conserved in all isolates, 
having no nucleotide variability. 
A table was compiled for all protein sequences for the results of the cNLS Mapper and 
NetNES 1.1, together with the scores of all predicted NLSs (Table 4). NLSs were predicted for 
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all putative protein products in TaVCV for all isolates, and for most isolates, the scores for all 
predicted NLSs ranged between 3-5. A notable exception is the Fiji isolate, where a monopartite 
NLS was predicted with a score of 9 for the N protein. The Hawaii, Guam, and Palau isolates 
had a putative N protein with a predicted monopartite NLS with a score of 4. This monopartite 
NLS was not predicted for the Samoa and Vanuatu isolates, though there were still predicted 
bipartite NLSs. A score of 3-5 corresponds to a distribution of the protein between the nucleus 
and cytoplasm, while a score of 8-10 corresponds to an exclusive localization of the protein in 
the nucleus. The monopartite NLS in particular corresponds to the RGTKRPNPAAT sequence in 
Hawaii, Guam, and Palau isolates, whereas this corresponds to the RGTKRPNPAVF sequence in 
Fiji. NESs were predicted for all proteins except for the phosphoprotein (P), which was a 
consistent property in all isolates. 
 At the gene junction, the 3’-leader site, and the 5’-trailer site, there is a short 13-16 
nucleotide sequence 3’-AAUUCUUUUUGGG(UUG)-5’ which follows after each ORF (with the 
exception of the 3’-leader site, which lacks any ORF to precede it). This site downstream of the 
L gene in all isolates contains the 13 nucleotide sequence 3’-AAUUCUUUUUGGG-5’ though 
the other nucleotide sequences following other genes are at least 15 nucleotides, with 3’-
AAUUCUUUUUGGGUU-5’. This sequence is well-conserved between all isolates of TaVCV. 
This site is important for viral mRNA, as the poly-U region of the sequence contributes to 
polymerase stuttering, which is a random event that causes RdRp, together with its nascent 
(positive-sense) RNA, to move back one nucleotide and either continue or release the RNA. 
Presumably, the polymerase stuttering process may repeat several times, creating long poly(A) 
tails on the nascent mRNA despite a short run of uracil nucleotides on the virion-sense strand. 
This feature of polyadenylation was observed by Hunt et al. (1984) in a mutant of Indiana 
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vesiculovirus, which is a member of the genus Vesiculovirus in the family Rhabdoviridae. As 
this site is conserved in all isolates despite the high nucleotide diversity, it is clear that this 
particular sequence is crucial for the virus and expression of viral proteins. Another conserved 
genetic feature in all TaVCV isolates is the 3’-UGUU-5’ in the 3’-leader sequence, characteristic 
of all rhabdoviruses. 
 Most of the proteins in the isolates have a similar length, but, notably, there is an extra 
segment in the Hawaii and Guam isolates at the N-terminal region of the nucleoprotein. In these 
isolates, the additional fragment is 34 amino acids in length but is not conserved across the other 
isolates, implying that this fragment of the nucleoprotein is not critical to its functionality. 
Interestingly, the aforementioned polymerase stuttering site (3’-AAUUCUUUUUGGGUUG-5’) 
was present within the part of the coding sequence that codes for this particular 34 amino acid 
fragment. 
 Considering the lengths of the ORF products, it is clear that the nucleoprotein is the most 
varied, with Palau, Samoa, and Vanuatu isolates sharing a length of 453 aa, while Hawaii and 
Guam isolates share a length of 487 aa, which is the length of the 453 aa in the aforementioned 
isolates with the 34 aa fragment discussed previously. Fiji stands out from these isolates with a 
length of 502 aa. Comparing the amino acid sequence of the Fijian nucleoprotein to the other 
isolates examined in this study, the sequence diverges completely starting at Val-411. In Revill et 
al. (2005a), the amino acid sequence of the nucleoprotein contained three groups of basic amino 
acids resembling the nuclear localization signal of other nucleoproteins belonging to different 
rhabdoviruses. These groups are 402RGTKR406, 421HPTKKRTWK429, and 462RGKHHR467. The 
latter two groups are not seen in Hawaii, Guam, Samoa, Palau, or Vanuatu isolates, though the 
RGTKR motif is present and conserved in all examined isolates. This implies that there is a key 
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role of the RGTKR motif as the nuclear localization signal for the nucleoprotein, though it 
appears that the other motifs are not as necessary for viral replication in the nucleus. The cNLS 
Mapper results for the nucleoprotein were mostly consistent with this observation, though it 
failed to predict a NLS containing the RGTKR motif in Samoa and Vanuatu isolates. The 
monopartite NLS predicted for Hawaii, Guam, Palau, and Fiji all contained the RGTKR motif, 
but the score for the Fiji isolate was drastically different for Fiji, which scored 9 as opposed to 4 
in the other isolates. As a score of 9 indicates that the protein of interest would be exclusively 
localized to the nucleus, this would be consistent with the electron microscopy data by Revill et 
al. (2005a) in which the virus was observed to be distributed exclusively in the nucleus. For the 
other isolates, this exclusivity may not necessarily be observed, as a score of 4 indicates a 
distribution between the nucleus and cytoplasm. This implies that this distribution could be 
observed in other TaVCV isolates but an electron microscopy experiment was not performed 
with these isolates. Despite having a score of 4, these predictions may still be consistent with the 
trend of Nucleorhabdovirus genus members having the unique ability to replicate and assemble 
in the nucleus, as other viruses that replicate and assemble in the cytoplasm typically lack these 
signals and do not depend on them for their functions. With the current sequence data, the 
important part of the nucleoprotein sequence is the domain spanning amino acids 1-410 in the 
Fijian isolate and the corresponding domain in the other TaVCV isolates. Notably, if a nucleotide 
was added to the part of the gene coding for the nucleoprotein in the Fijian genome, the length of 
the resulting protein product is 453 aa, comparable to the other isolates. The rest of the sequence 
becomes more similar to the sequences of the other isolates established in this study, raising the 




 There is a higher degree of sequence conservation with regard to the other five main 
functional proteins, especially with genes 3 and the ORF coding for glycoprotein (G), which 
have a uniform amino acid sequence length across all studied isolates, which implies that the 
domain that is necessary for the function of these proteins is within the full length of each 
respective protein (1-287 for gene 3, 1-588 for G). For P, the only isolate with a shorter length is 
the Palau isolate with a length of 259 aa, due to a frameshift which causes the sequence to 
diverge starting at the 217th aa. Thus, the functional domain of P is contained within amino acids 
1-216. There is a hydrophilic pocket noted in residues 108-200 of the Fijian isolate and this 
domain is mostly conserved between isolates. Notably, the frameshift in the P gene of the Palau 
isolate could be due to a sequencing error, as adding an A where the frameshift occurs results in 
a protein sequence very similar to the other isolates. 
P is the only major protein in the genome which does not have a predicted NES. 
Curiously, cNLS Mapper did not predict a monopartite NLS with a high score in the P protein of 
TaVCV. In MMV, there is a predicted monopartite NLS with a score of 10 which corresponds to 
the motif 154PSIKRKAEAM163, while in the more closely related putative nucleorhabdovirus 
Morogoro maize-associated virus (MMaV), there is a predicted monopartite NLS with a score of 
9 which corresponds to the motif 169PNPKRKKEAM178 (Read et al., 2019). The corresponding 
amino acid sequence in TaVCV is 157PDSAKRQEAL166 (Hawaii; for Guam and Palau, 159-T 
replaces 159-S), 157PDATKKQEAL166 (Samoa and Vanuatu), or 157PDQAKKQEAL166 (Fiji). A 
typical marker of NLSs is the presence of lysine and arginine residues; this fragment in TaVCV 
has less of these residues compared to the corresponding motifs in MMV and MMaV. As P is a 
co-factor of RdRp, a high scoring predicted monopartite NLS would support solely nuclear 
replication with this genus, but TaVCV seems to have an exception with its deviated motif. 
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 The 3 protein seems to be relatively well-conserved, as all isolates have the same length 
of the putative protein product, despite a lack of definitive evidence concerning the function of 
this protein. It is believed to be a putative movement protein in other Nucleorhabdovirus genus 
members (Huang et al., 2005; Min et al., 2010), but when this virus was first characterized, there 
was a low protein sequence identity to the analogous protein product in MMV. There are both 
predicted bipartite NLS (scoring in the range of 3-5 across different isolates) and predicted NES. 
The sequence of the predicted NES is the conserved motif 55LQFTSLTI62 found in all isolates, 
visualized in Fig. 2.2. While the NetNES score is lower for the Fiji isolate, some residues still 
surpass the threshold score for a prediction. 
The Hawaii and Guam isolates have an additional 14 amino acid fragment at the N-
terminus of M, similar to the nucleoprotein in those isolates. This fragment is absent in the other 
isolates, and thus the functional domain of M is contained in amino acids 1-235 in the Fiji, Palau, 
Samoa, and Vanuatu isolates and the analogous domain in the Hawaii and Guam isolates. Similar 
to other M gene products in other rhabdoviruses that infect plants and animals, there is a 
69HHIIRNK75 cluster of basic residues upstream of a YXG motif shared by the Fiji, Samoa, and 
Vanuatu isolates. This is mostly conserved in the Hawaii, Guam, and Palau isolates but instead 
contains the cluster 69HHIVRSK75 upstream. Isoleucine and valine are both amino acids with 
nonpolar side chains, and, notably, the codons that code for isoleucine (ATT, ATC, ATA) can be 
mutated into the codons that code for valine (GTT, GTC, GTA) and vice-versa by an A/G 
missense mutation. Asparagine and serine are both amino acids with polar side chains, and like 
isoleucine and valine contain similar codons that can interchange the amino acid with an A/G 
nonsense mutation (AGT or AGC for serine and AAT or AAC for asparagine). Notably, the 
amide functional group in the side chain of asparagine is a more polar functional group than the 
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alcohol functional group of serine. These modifications presumably have an overall minor effect 
on the protein. 
The glycoprotein (G) was a consistent length in all isolates and all shared the six 
conserved glycosylation signals (N-X-S/T). Interestingly, before residue 35, some of the amino 
acids showed relatively little similarity; many of the amino acid differences between sequences 
are attributable to a hypervariable segment of the coding region. This might imply that some of 
the residues in this fragment may not contribute as much to the functionality of the glycoprotein; 
this segment is also void of any glycosylation signals. Interestingly, Revill et al. (2005a) noted 
that the 70 kDa virion-associated polypeptide has an N-terminal sequence of VVDLNRN. This 
N-terminal sequence is associated with a protein that starts at residue 25 of the Fijian isolate, 
lending credence to the earlier assertion that the early protein fragment is not as critical to the 
overall function of the glycoprotein. Some of the first few amino acids in the fragment are 
leucine and other hydrophobic residues (such as valine and isoleucine), associated with an NES. 
When all G protein sequences were analyzed with NetNES, many of the residues in the first 12-
17 amino acids had high NES scores, corresponding to predicted NESs (Fig. 2.3). Therefore, it 
could be speculated that the protein is first expressed fully, which allows the glycoprotein in the 
assembled virus to be exported out of the nucleus, after which the fragment containing the 
nuclear export signal is later removed from the glycoprotein. 
A conserved domain search of each protein reveals only a few results: pfam17055, or 
viral matrix protein M2 domain (the hit spans the entirety of the matrix protein M with the 
exception of the 14 amino acid fragment in the Hawaii and Guam isolates); pfam00946, or 
Mononegavirales RNA-dependent RNA polymerase domain (the search hit spans residues 143-
1075 in Hawaii, Guam, Palau, and Fiji, but 41-1075 in Samoa and Vanuatu); and TIGR04198, or 
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paramyxovirus family mRNA capping enzyme or mRNA (guanine-7-)methyltransferase domain 
(the search hit spans residues 1176-1922 in Hawaii, Guam, and Palau, and 1176-1924 in Fiji, 
Samoa, and Vanuatu). The family Paramyxoviridae is a family which belongs to the order 
Mononegavirales, the same order that the family Rhabdoviridae is classified under (“ICTV”, 
2019). While the functional domain of each protein is implied with the differences between the 
isolates, especially in the case of the nucleoprotein as discussed earlier, information regarding 
protein domains relevant to the genus Nucleorhabdovirus is lacking except for the earlier 
conserved domain search results. 
 From a comparison of the complete predicted protein and nucleotide sequences of the L 
gene, minimum nucleotide identity of 78% is observed from the genomic sequences of TaVCV, 
though the protein identity is higher, by comparison, having high degrees of identity by at least 
90% (Table 5). A similar observation is found when comparing the full genome as nucleotide 
sequences and the whole viral proteome as protein sequences, though the minimum protein 
identity decreases very slightly to 89% (Table 6). A significant portion of the nucleotide 
diversity between the isolates is thus due to silent mutations, which do not change the resulting 
amino acid, and the rest of the mutations are missense mutations, changing the coded amino acid 
to a different one. This can have varied effects on a protein, as changing an amino acid to a 
similar one might not affect the function of the protein as much as a change to a dissimilar amino 
acid. A missense mutation can occur such that a critical function of a viral protein is impaired, 
though viruses impaired in this way have decreased fitness. 
Phylograms generated using the L genes (Fig. 2.4a, b) of all the isolates together with 
MMaV and all other officially recognized nucleorhabdoviruses grouped Hawaii and Guam 
isolates together, as was the case with Samoa and Vanuatu isolates. The inclusion of the Palau 
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isolate into a clade together with Hawaii and Guam had high bootstrap support (100%). The Fiji 
isolate grouped with the Samoa and Vanuatu isolates in a clade when the maximum likelihood 
method was used, but it grouped with Hawaii, Guam, and Palau in a clade when the neighbor-
joining method was used. A low bootstrap support (60% for maximum likelihood and 63% for 
neighbor-joining) was observed for the Fiji isolate. Samoa and Vanuatu isolates grouped 
separately from the other isolates in the maximum likelihood phylogram. TaVCV isolates 
grouped together in a clade separate from the other members of the Nucleorhabdovirus genus. 
Additionally, the putative nucleorhabdovirus MMaV grouped together with the TaVCV isolates 
one node further with a relatively high bootstrap support (76% for maximum likelihood, 100% 
for neighbor-joining). Phylograms generated by the whole viral proteomes (Fig. 2.5a, b) showed 
a slightly different result, as Fiji grouped together in a clade with Hawaii, Guam, and Palau in 
both maximum likelihood and neighbor-joining methods with a relatively low bootstrap support 
(62% for maximum likelihood and 78% for neighbor-joining). Notably, small terminal branch 
length was observed for all isolates of TaVCV compared to the terminal branch length observed 
for the other nucleorhabdoviruses, supporting their close relationship as TaVCV isolates. The 
longest terminal branch among TaVCV isolates belonged to the Fiji isolate, though the total 
branch length from the TaVCV ancestral node was similar when the neighbor-joining method 
was used for both the L gene and the whole viral proteome. 
A high protein identity was noted for Hawaii and Guam isolates with 99% identity, and 
the Samoa and Vanuatu isolates were very close to having 100% identity, with a difference of 
only three amino acids in the L gene and only eight amino acids in the whole viral proteome. 
This would imply that the movement of TaVCV between Hawaii and Guam was a recent 
occurrence, with the same applying to the movement of TaVCV between Samoa and Vanuatu. 
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This is further supported by the branches observed in the phylogenetic trees. This is also the first 
known observation of TaVCV prevalence in Guam, which has not been reported to date. 
The Palau isolate was observed to be more distantly related with an 88% nucleotide 
identity compared to the Hawaii and Guam isolates, but a high protein identity of 97% was still 
observed when comparing the Palau isolate to Hawaii and Guam isolates each. As discussed 
previously, a high nucleotide diversity may not correspond with high protein diversity. This 
would indicate that a common ancestor to Palau, Hawaii, and Guam TaVCV isolates was first 
spread to one of the three locations, then later distributed to the other two locations, with Hawaii 
and Guam isolates having a closer period of incidence. Interestingly, a taro cross-breeding 
project was conducted by Trujillo et al. in 2002 in response to the TLB epidemic devastating taro 
crops; the “Ngeruuch” variety from Palau was crossed with “Maui Lehua” to yield a hybrid that 
had preferable agronomic characteristics in addition to the TLB resistance from the “Ngeruuch” 
variant. The spread of TaVCV could have happened between Palau and Hawaii in this way, as 
TaVCV was not seen in Hawaii taro until a first report detailed its presence in 2013 (Long et al., 
2014) and import of taro from elsewhere to Hawaii is usually restricted. 
In a similar fashion, Fiji, Samoa, Tonga, and Vanuatu all participate in taro exports 
(Sami, 2011). A nearly identical genome of TaVCV found in Samoa and Vanuatu samples would 
suggest a very recent infection of taro from one country to the other. As TaVCV symptoms do 
not emerge until taro is mature and are difficult to spot when the virus does not cause severe 
symptoms, the virus could have been infecting taro that appeared healthy before its movement 
between countries. The nearly identical genomes suggest recent movement, as both countries 
have been documented to have some prevalence of TaVCV years prior to this study. Currently, 
having only one genome sequenced for each location limits our knowledge of the movement 
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paths of TaVCV and if other genomes were found, that could completely alter the conclusion of 
the movement of TaVCV across the Pacific. 
 
Isolate Number of Total Reads TaVCV-Specific Reads 
Hawaii 3625424 1573238 
Samoa 3556006 241630 
Guam 12090920 27098 
Palau 6349336 31994 
Vanuatu 10410134 415500 
 
Table 2. Table for the number of reads obtained for each TaVCV-positive isolate and number of 
TaVCV-specific reads from each set of data. 
 
 Length (aa) 
Isolate N P 3 M G L 
Hawaii 487 271 287 249 588 1926 
Guam 487 271 287 249 588 1926 
Palau 453 259 287 235 588 1926 
Samoa 453 271 287 235 588 1928 
Vanuatu 453 271 287 235 588 1928 
Fiji 502 271 287 235 588 1928 
 
Table 3. A table detailing the amino acid length of the six major ORFs in TaVCV (N, P, 3, M, 





 NLS (cNLS Mapper) NES (NetNES 1.1) 
Protein Length (aa) Predicted Score Predicted 
N 453-502 Yes 4M (H/G/P) or 9M (F), 3.1-4.3B Yes 
P 259-271 Yes 3-3.3B No 
3 287 Yes 3-5B Yes 
M 235-249 Yes 3-4.8B Yes 
G 588 Yes 3-3.7B Yes 
L 1926-1928 Yes 3-5M (all except F), 3-4.5B Yes 
 
Table 4. A table depicting each putative protein paired with their range of predicted amino acid 
lengths, NLSs and NESs using cNLS Mapper and NetNES 1.1, respectively. All ORFs in all 
putative protein products of all isolates have a predicted NLS. A monopartite NLS is predicted in 
all putative N except for Samoa and Vanuatu, and in all putative L except for Fiji. Additionally, 
all isolates contain ORFs that code for proteins with a predicted NES except for the 
phosphoprotein (P). If isolate(s) is/are not specified for the score, assume that this value applies 





Table 5. Comparison table of the isolates studied here, including the Fijian isolate (GenBank 
accession number NC_006942.1). This table was compiled by a comparison of the RdRp gene as 
both protein and nucleotide sequences. Values in the table are rounded to the nearest whole 
number. Minimum nucleotide identity of 78% can be observed when comparing isolates, but 





Table 6. Comparison table of the isolates studied here, including the Fijian isolate (GenBank 
accession number NC_006942.1). This table was compiled by a comparison of the whole viral 
proteome as compiled protein sequences, as well as the whole genomes of the isolates as 
nucleotide sequences. Values in the table are rounded to the nearest whole number. Minimum 
nucleotide identity of 78% can be observed when comparing isolates, but protein identity 





Fig. 2.2. Partial graphic of NetNES 1.1 results for gene 3 sequences in all isolates studied, 
together with the Fiji isolate. The NES score exhibited for each amino acid is calculated based on 
a post-processing algorithm which takes into account both the neural network (NN) and hidden 
Markov model (HMM) scoring; if this score exceeds 0.5 for a particular residue, NetNES marks 
the amino acid as a predicted NES. All isolates exhibit a predicted (leucine-rich) nuclear export 
sequence (NES) in the motif 55LQFTSLTI62. 
 
Fig. 2.3. Partial graphic of NetNES 1.1 results for glycoprotein (G) sequences in all isolates 
studied, together with the Fiji isolate. The NES score exhibited for each amino acid is calculated 
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based on a post-processing algorithm which takes into account both the neural network (NN) and 
hidden Markov model (HMM) scoring; if this score exceeds 0.5 for a particular residue, NetNES 
marks the amino acid as a predicted NES. All isolates exhibit a predicted (leucine-rich) nuclear 
export sequence (NES) in the first few amino acids of the protein sequence. 
 
Fig. 2.4a. Phylogenetic tree generated using the maximum likelihood method for the L genes (as 
amino acid sequences) of the TaVCV isolates and other members of the genus 
Nucleorhabdovirus. Morogoro maize-associated virus (MMaV, GenBank accession number 
MK063878.2) is a putative nucleorhabdovirus that is the most closely related viral species to 
TaVCV, but is not yet formally recognized by the ICTV. 1,000 bootstraps were performed. 




Fig. 2.4b. Phylogenetic tree generated using the neighbor-joining method for the L genes (as 
amino acid sequences) of the TaVCV isolates and other members of the genus 
Nucleorhabdovirus. Morogoro maize-associated virus (MMaV, GenBank accession number 
MK063878.2) is a putative nucleorhabdovirus that is the most closely related viral species to 
TaVCV, but is not yet formally recognized by the ICTV. 1,000 bootstraps were performed. 





Fig. 2.5a. Phylogenetic tree generated using the maximum likelihood method for the whole viral 
proteome (as compiled amino acid sequences) of the TaVCV isolates and other members of the 
genus Nucleorhabdovirus. Morogoro maize-associated virus (MMaV, GenBank accession 
number MK063878.2) is a putative nucleorhabdovirus that is the most closely related viral 
species to TaVCV, but is not yet formally recognized by the ICTV. 1,000 bootstraps were 





Fig. 2.5b. Phylogenetic tree generated using the neighbor-joining method for the whole viral 
proteome (as compiled amino acid sequences) of the TaVCV isolates and other members of the 
genus Nucleorhabdovirus. Morogoro maize-associated virus (MMaV, GenBank accession 
number MK063878.2) is a putative nucleorhabdovirus that is the most closely related viral 
species to TaVCV, but is not yet formally recognized by the ICTV. 1,000 bootstraps were 






CHAPTER 3: DISCOVERY AND MOLECULAR CHARACTERIZATION OF A 
PUTATIVE TARO TOTIVIRUS 
Introduction 
 Totivirus is a genus of the family Totiviridae, which contains members characterized by 
icosahedral virions which are roughly 40 nm in diameter containing a double-stranded (ds)RNA 
genome that encodes at least two proteins on the positive-sense strand, a capsid or coat protein 
(CP) and RNA-dependent RNA polymerase (RdRp). A putative slippery site located toward the 
end but before the stop codon of the gene coding for the CP is the location of a rarely occurring -
1 ribosomal frameshift which causes the expression of a CP+RdRp fusion protein (Brierley et al., 
1992; Brierley, 1995). There are seven recognized members of the genus Totivirus, although 
other putative totiviruses have also been reported. Typically, members of the genus Totivirus 
have been known to infect fungi, though there have also been findings in which putative 
totiviruses or totivirus-like viruses have infected hosts other than fungi. 
 Some totiviruses or totivirus-like viruses were isolated from plants, which include Papaya 
meleira virus from papaya (Abreu et al., 2015), Black raspberry virus F from black raspberry 
(GenBank accession number NC_009890), Ribes virus F from gooseberry (GenBank accession 
number ACA61232), and an unnamed dsRNA species from black currant (Cox et al., 2000). 
Additionally, a recent publication by Guo et al. in 2016 features such a putative totivirus, 
tentatively named the Panax notoginseng virus A, with a complete genome submitted to 
GenBank. Plant-infecting putative totiviruses have yet to be recognized by the ICTV, but the 
lack of publications associated with some of these submissions challenges the recognition 
process. Any proposal for the recognition of new viruses requires satisfying the relevant viral 
family’s demarcation criteria and must also be accompanied by a publication for those viruses. 
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Although Black raspberry virus F was in consideration for being recognized as a member of the 
family Totiviridae as it had sufficiently met the demarcation criteria with approximately 50% 
protein sequence identity to other currently recognized totiviruses, there were no publications 
available and thus its recognition could not be finalized. Despite the current circumstances 
regarding the recognition of plant-infecting totiviruses and totivirus-like viruses, the current 
publication for Panax notoginseng virus A demonstrates the potential of finding more of these 
viruses. 
 Here, we report the identification and characterization of a novel virus associated with 
taro discovered via high-throughput sequencing of a sample acquired from Samoa, which most 
likely represents a novel species of totivirus belonging to the genus Totivirus. 
 
Materials and Methods 
Double-Stranded (ds)RNA Extraction (Large-Scale) 
 The following method is based on the plant viral double-stranded RNA (dsRNA) protocol 
by Morris and Dodds (1979), Bar-Joseph et al. (1983) and Dodds et al. (1984). About 5 g of 
symptomatic leaf tissue from Hawaii or Samoa was ground into a powder in liquid nitrogen 
using a mortar and pestle, which was pre-cooled overnight in a -20 °C freezer. The powdered 
leaf tissue was then added to 200 mL of dsRNA extraction buffer (10X STE 18 mL, 10% SDS 
30 mL, β-Mercaptoethanol 2 mL, dH2O 72 mL, saturated phenol 40 mL, chloroform 40 mL; 10X 
STE = Tris-HCl 61.0 g, NaCl 58.0 g, EDTA 3.7 g, dH2O to 1000 mL, pH 8.0), then stirred with a 
magnetic stir bar for 45-60 minutes at 4 °C. The solution was then transferred to a 250 mL bottle 
and centrifuged at 8,000 rpm for 10 minutes. The aqueous phase was transferred to a new bottle, 
then 0.2 volumes (with respect to the aqueous phase volume) of EtOH was added. 2 g of CF-11 
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cellulose powder was added to the solution, which was then gently shaken on an orbital shaker 
for 30 minutes at room temperature (RT). This solution with cellulose powder was added to a 
column and the liquid was allowed to flow through, then the column was washed with at least 
100 mL of 1X STE containing 16.5% (v/v) EtOH. The liquid was then purged from the cellulose 
and the dsRNA was then eluted into a 50 mL centrifuge tube with three 10 mL aliquots of 1X 
STE, each of which was purged after each elution. 6 mL EtOH (0.2 volumes with respect to 
elution volume), then 1.5 g of CF-11 cellulose powder was added to the eluate and gently shaken 
on an orbital shaker overnight at RT. The solution with powder was then added to a column, the 
liquid was allowed to flow through and the column was then washed with at least 100 mL of 1X 
STE containing 16.5% (v/v) EtOH. The liquid was then purged from the cellulose, and the 
dsRNA was then eluted into a 15 mL centrifuge tube with three aliquots of 3 mL 1X STE, each 
of which was purged after each elution. The tubes were then spun in a centrifuge for 1 minute to 
pellet the cellulose, and the supernatant was then transferred to a 30 mL Corex centrifuge tube. 
0.9 mL of 3 M sodium acetate (pH 5.2) was then added to the transferred solution, and the tube 
was filled as close to the top as possible with 95% EtOH (about 20 mL). The tube was sealed 
with Parafilm, inverted to mix the solution well and incubated overnight at -20 °C. 
 The next day, the tubes were centrifuged at 12,000 rpm for 30 minutes. The supernatant 
was then decanted, and the pellet was then resuspended in 500 µL of molecular-grade (nuclease-
free) water. The dsRNA solution was then concentrated using an Amicon Ultra centrifugal filter 
(50 kDa molecular weight cutoff). 
 
Preparation of cDNA Library for Next-Generation Sequencing 
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 The dsRNA eluate was used as a template for reverse transcription. 1 µL dsRNA, 1 µL 
10 µM Up-dN6 primer (5’-GCCGGAGCTCTGCAGAATTCNNNNNN-3’), 10 µL nuclease-free 
H2O were mixed, incubated at 95 °C for 8-10 min, then immediately chilled on ice for at least 1 
min and spun down by centrifugation. To this reaction, 4 µL 5x First-Strand Buffer, 2 µL 0.1 M 
dithiothreitol, 1 µL (40 U/µL) rRNAsin Ribonuclease Inhibitor and 1 µL SuperScript III Reverse 
Transcriptase (200 U/µL) were added. The reaction was incubated at 25 °C for 5-10 min, then 50 
°C for 60 min, then inactivated by incubating at 98 °C for 2 min, followed by chilling on ice and 
a brief centrifugation step. 0.5 µL RNAse H (1.5 U/µL) was added and incubated at 37 °C for 30 
min. 480 µL of nuclease-free water was then added to the reaction and purified and concentrated 
using an Amicon Ultra centrifugal filter (50 kDa molecular weight cutoff). 
 The eluate was mixed with an equal volume of 2x GoTaq Green Master Mix and 
incubated in a thermocycler with the following cycling conditions: 95 °C for 7 min, then 10 
cycles of 95 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min, followed by 72 °C for 7 min. 1 
µL of the previous reaction, 2 µL 10 µM Up primer (5’-GCCGGAGCTCTGCAGAATTC-3’), 7 
µL nuclease-free H2O, 10 µL 2x GoTaq Green Master Mix were mixed and incubated in a 
thermocycler with the following cycling conditions: 95 °C for 7 min, then 35 cycles of 95 °C for 
1 min, 55 °C for 1 min and 72 °C for 1 min, followed by 72 °C for 7 min. This reaction was then 
purified using an Amicon Ultra centrifugal filter (50 kDa molecular weight cutoff). Polymerase 
chain reaction (PCR) products which ranged from 300-1000 base pairs (bp) of length were then 
sequenced on the MiSeq platform for high-throughput sequencing. Sequencing data was then 
used to construct the genomes of viral sequences with the help of Galaxy version 19.05 and 




Rapid Amplification of cDNA Ends (RACE) 
 Primers were designed based on the tentatively assembled viral genomes such that the 
terminal sequences can be generated by reverse transcription. 
In a sterile microcentrifuge tube, 1 µL dsRNA, 1 µL 10 µM NeoTaTV_N primer (5’-
TGATTGTCAGCCCAAGACCA-3’) or NeoTaTV_C primer (5’-
GCTGGTCCAAGATGTAACGGA-3’) for 5’-RACE or 3’-RACE respectively, 10 µL nuclease-
free H2O were mixed, incubated at 95 °C for 8-10 min, then immediately chilled on ice for at 
least 1 min and spun down by centrifugation. To this reaction, 4 µL 5x First-Strand Buffer, 2 µL 
0.1 M dithiothreitol, 1 µL (40 U/µL) rRNAsin Ribonuclease Inhibitor and 1 µL SuperScript III 
Reverse Transcriptase (200 U/µL) were added. The reaction was incubated at 50 °C for 60 min, 
then inactivated by incubating at 98 °C for 2 min, followed by chilling on ice and a brief 
centrifugation step, which was then purified by the QIAgen PCR Purification Kit. 
 The eluate was then used as a template for terminal deoxynucleotidyl transferase (TdT) 
tailing. 10 µL of the eluate containing cDNA, 5 µL 5x TdT buffer, 1.25 µL 100 µM dGTP (for 
5’-RACE) or dATP (for 3’-RACE), 8.25 µL nuclease-free dH2O and 0.5 µL TdT (15 U/µL) were 
mixed and incubated at 37 °C for 30 min, then inactivated by heating to 75 °C for 10 min. This 
reaction was also purified by the QIAgen PCR Purification Kit. 
 1 µL dGTP or dATP-tailed cDNA, 1 µL 10 µM Poly-dC_5_RACE primer for 5’-terminal 
dGTP-tailed cDNA (5’-TTACTAATATCCCCCCCCCCCC-3’) or Poly-dT_3_RACE primer for 
3’-terminal dATP-tailed cDNA (5’-GACCACGCGACGTGTCGAVTTTTTTTTTTTTTTT-3’) 
respectively, 7 µL nuclease-free dH2O, 10 µL 2x GoTaq Green Master Mix was mixed, then 
incubated in a thermocycler at 95 °C for 5 min, then 52 °C (for 5’-terminus) or 37 °C (for 3’-
terminus) for 2 min, then 72 °C for 40 min. 1 µL 10 µM terminal primer that was used for cDNA 
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synthesis was then added to the reaction, then the reaction was incubated in a thermocycler for 
30 cycles of 95 °C for 1 min, 60 °C for 1 min, 72 °C for 3 min with a final extension step of 72 
°C for 15 min. Each reaction was diluted at a 1:100 ratio in nuclease-free dH2O for a half-nested 
PCR. This half-nested PCR used another primer designed to anneal further down the terminal 
sequence. 
 1 µL dGTP or dATP-tailed cDNA, 1 µL 10 µM Poly-dC_5_RACE primer for 5’-terminal 
dGTP-tailed cDNA (5’-TTACTAATATCCCCCCCCCCCC-3’) or Poly-dT_3_RACE primer for 
3’-terminal dATP-tailed cDNA (5’-GACCACGCGACGTGTCGAVTTTTTTTTTTTTTTT-3’), 
1 µL 10 µM TaTV_N primer (5’-GTCTAACGAAACTGTCCAT-3’) or TaTV_C primer (5’-
CGTTACATGTGTTGTTGTGA-3’) for 5’-RACE or 3’-RACE respectively, 7 µL nuclease-free 
dH2O, 10 µL 2x GoTaq Green Master Mix was mixed, then incubated in a thermocycler at 95 °C 
for 5 min, then 30 cycles of 95 °C for 1 min, 55 °C for 1 min, 72 °C for 3 min with a final 
extension step of 72 °C for 15 min. This reaction was run on an agarose gel and a band 
corresponding to the expected size was cut from the gel, extracted by a centrifugation step 
through filter paper at maximum speed (21,130 g) for 2 min. 
 0.3 µL of pGEM T-Easy vector, 3.7 µL gel eluate, 5 µL 2x Rapid Ligation Buffer and 1 
µL T4 DNA Ligase (3 U/µL) were mixed and incubated overnight at RT. The following day, a 
tube containing chemically competent E. coli DH5α cells was thawed on ice for 10 min, then 2-5 
µL of the ligation reaction was added to the tube of cells, flicked gently 4-6 times and continued 
incubation on ice for 60 min. The tube was then added to a water bath at exactly 42 °C and 
incubated for 30-45 sec before immediately placing the tubes back on the ice for 2 min. 450 µL 
of Super Optimal Broth (SOB) was then added to the tube and incubated at 37 °C for 45 min 
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with shaking (200-300 rpm). 250 µL was then plated on MacConkey Agar containing ampicillin 
antibiotics at a concentration of at least 100 µg/mL, then incubated overnight at 37 °C. 
Bacteria colony PCR using T7 and SP6 primers was then performed for each white 
colony that grew on the agar, and colonies that amplified products at roughly the expected size 
were then grown in Luria-Bertani medium (LB) containing ampicillin at a concentration of at 
least 100 µg/mL overnight. The QIAgen Spin Miniprep Kit was used to purify the plasmid 
containing the insert of interest and the plasmid that was eluted from the kit was then sequenced. 
 
Sequence Analysis and Phylogeny 
 MEGA-X (Kumar et al., 2018) was used for protein sequence alignment of L genes using 
the ClustalW algorithm. This alignment was then used for the generation of a phylogram with the 
neighbor-joining and maximum likelihood methods, which were each performed with 1,000 
bootstrap replicates. 
 












Table 7. List of primers used in this study. NeoTaTV_N and NeoTaTV_C are both primers used 
for the reverse transcription reaction and the first round of PCRs for their respective terminal 
RACE procedure. TaTV_N and TaTV_C are both primers used for the half-nested PCRs 
following the first round of PCRs to improve specificity that may have been an issue using only 
one primer set. 
 
Results and Discussion 
 The taro virome remains an understudied aspect of its pathology, as most of the concern 
for taro is focused on the devastating alomae disease, caused by co-infection of CBDaV and 
TaBV, and the severe impact of TaVCV across the Pacific. Sanger sequencing, which can 
generate sequence reads of 500 to 1,000 bp, remains a relevant tool and plays a role in the 
sequencing of viruses and their genomes. Overlapping regions of primer pairs would often be the 
ideal strategy to sequence new viral genomes, but the discovery of new viruses was difficult 
when using this method. Some RNA viruses that have been sequenced in the past used an RNA 
purification method, including the method by Morris and Dodds (1979) for purifying dsRNA 
viruses and species of other RNA viruses in the process of replication. If the titer of a virus was 
high enough, the dsRNA eluate could be visualized on an agarose gel. The segments containing 
potential viral genomes would then be excised and sequenced with tagged random primers, 
creating a cDNA library containing a pool of viral sequences. This method was useful but was 
often challenging and required many unique sequences, which could be time-consuming if some 
of those sequences contributed little to no additional information. With the emergence of high-
throughput sequencing (HTS) as a potential route for sequencing new viruses, much of this 
method is streamlined and only requires the steps of the experimental method up until generating 
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a cDNA library before preparing the sample for the HTS method. An added benefit of this is the 
ability to find viral sequences despite a low titer of a virus in plant materials used for the 
experiment. This method may not always result in full genomes, but if any gaps are present from 
missing sequences, there is always the potential to design primer sets to fill in the gaps of viral 
scaffolds. The terminal ends of viral sequences must also be confirmed by RACE as assemblies 
generated may contain extra sequence fragments that are not actually in the true sequence of the 
virus. 
 The complete sequence of the totivirus dsRNA genome is 4960 bp in length with a G/C 
content of 48.9%. Two open reading frames (ORFs), designated ORF1 and ORF2 from the 5’ to 
3’ end, were found on the same strand. ORF1, in a +3 frame, starts from nucleotide (nt) 51 and 
stops at nt 2354 with a UAG stop codon. The protein coded by ORF1 has been calculated to be a 
molecular weight of 86.1 kDa. ORF2, in a +2 frame, starts from nt 2684 and stops at nt 4909 
with a UGA stop codon. The protein coded by ORF2 has been calculated to be a molecular 
weight of 85.2 kDa. Both ORFs are separated by 329 nts, the 5’ untranslated region consists of 
50 nts, and the 3’ untranslated region consists of 51 nts (Fig. 3.1). A putative slippery site was 
found within ORF1 which consists of a heptanucleotide sequence 2243GGGTTTT2249 that, if a -1 
frameshift occurred at this site, could generate a fusion protein of ORF1 and ORF2 that is 1619 
amino acids long with a predicted molecular weight of 183.75 kDa (Fig. 3.1) (Yusop et al., 2019; 
Ghabrial, 2008). 
 The putative protein coded by ORF1 is most similar to the putative CP of Panax 
notoginseng virus A (GenBank accession number NC_029096.1) with a 49% amino acid 
sequence identity determined by LALIGN (https://embnet.vital-
it.ch/software/LALIGN_form.html). CPs from other viruses with a significant similarity include 
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Pterostylis sanguinea totivirus A and Black raspberry virus F, which are both totiviruses. Some 
CPs from other totiviruses with a significant similarity include Saccharomyces cerevisiae virus 
L-A (ScVL-A), Tuber aestivum virus 1 (TaV1) and Scheffersomyces segobiensis virus L 
(SsVL), though the similarity with these viruses was restricted to the LA-virus coat domain 
(pfam09220), a conserved region found in all of these proteins. 
 A global protein sequence alignment conducted via LALIGN with ORF2 to the putative 
RdRp of Panax notoginseng virus A demonstrated that the two proteins had a 55% amino acid 
sequence identity. When ORF2 was searched against ScVL-A, TaV1, and SsVL, protein 
sequence identity ranged from 32-40%. The RdRp 4 domain (pfam02123) was shared between 
these sequences and found in ORF2. All of the eight conserved domains shared by all RdRps in 
totiviruses were also found in ORF2 (Bruenn, 1993), as shown in Fig. 3.2. Additionally, a global 
protein sequence alignment between the fusion protein of ORF1+ORF2 and the CP+RdRp fusion 
protein of Panax notoginseng virus A demonstrated a 54% amino acid sequence identity. 
 These characteristics of the ORFs strongly suggest that this dsRNA may be representative 
of a dsRNA virus belonging to the genus Totivirus, family Totiviridae, for which the name Taro-
associated totivirus L (TaTV-L) was proposed. As expected, when a phylogenetic tree was 
generated using RdRp amino acid sequences from several select members of the family 
Totiviridae, TaTV-L formed a monophyletic clade together with other members of the genus 
Totivirus (Fig. 3.3a, b). The demarcation criteria for the family Totiviridae is 50% amino acid 
sequence identity, and the amino acid identities described earlier are close enough to the criteria 
that it would warrant the recognition of this species as a unique totivirus. 
 The viruses recognized by ICTV which belong to the genus Totivirus have all been noted 
to infect fungi (http://ictvonline.org/virusTaxonomy.asp). It is, therefore, possible that TaTV-L is 
69 
 
a virus that infects a fungus associated with Colocasia esculenta. On the contrary, there were no 
symptoms on the leaf sample used for the dsRNA extraction that indicated that there was an 
infection by a fungus. 
 Among the sequences gathered through HTS, sequences of a totivirus were found in the 
Samoan sample which marked the presence of a virus that had not yet been sequenced in 
GenBank, as the closest related virus was found to be Panax notoginseng virus A with a low 
protein identity. This factor alone made the sequencing of this virus potentially useful, but there 
are potential circumstances which complicate the issue of truly determining whether this is a 
bona fide plant virus or otherwise. The currently recognized species of the Totivirus genus have 
only fungal hosts. As fungal diseases have been recorded for taro, it is difficult to rule out the 
possibility that the totivirus infects a fungus associated with taro. As totiviruses are naturally 
dsRNA, a relatively high titer is also to be expected from a dsRNA extraction. With the current 
circumstances, it is difficult to speculate how the totivirus became associated with taro, as other 
isolates did not exhibit the symptoms of a totivirus. The symptoms that this totivirus might cause 
are also unclear, as interactions between totiviruses and plants have not been explored in depth. 
While the taro leaf sample used for the dsRNA extraction did not seem to exhibit any unique 
symptoms, the presence of this virus in the dsRNA eluate was confirmed by PCR. Gradually, 
more publications of totiviruses in plants are being produced. 
 Although the results of this study led to the discovery of only one undocumented virus, 
this serves as a proof of concept of the potential of HTS in the discovery of new viruses in the 
future. While this study covered the viromes of five regional isolates, there are other places that 
warrant investigation, and the reports of more unique viruses that have been found to infect taro 





Fig. 3.1. Schematic representation of the Taro-associated totivirus L genome. A heptanucleotide 
sequence, the putative site of the -1 frameshift, marks a genetic feature belonging to members of 
the genus Totivirus. If this frameshift occurs, a fusion protein combining ORF1 and ORF2 may 
be rarely expressed. Note that this figure is not drawn to scale. 
 
 
Fig. 3.2. The eight conserved domains common to the family Totiviridae, including the 
Leishmania RNA virus 1 (LRV1, genus Leishmaniavirus), Trichomonas vaginalis virus 1 (TvV1, 
genus Trichomonasvirus), Giardia lamblia virus (GlV, genus Giardiavirus), and the putative 
totivirus TaTV-L. The numbers between each sequence fragment represent the number of amino 
acids between each domain. Asterisks underneath the protein sequences denote identical residues 





Fig. 3.3a. Phylogenetic tree generated with the maximum likelihood method. Asterisks (*) 
denote species used in the phylogenetic tree that are not yet officially recognized as members of 
the genus Totivirus. Taro-associated totivirus L groups together in a clade with other totiviruses 





Fig. 3.3b. Phylogenetic tree generated with the maximum likelihood method. Asterisks (*) 
denote species used in the phylogenetic tree that are not yet officially recognized as members of 
the genus Totivirus. Taro-associated totivirus L groups together in a clade with other totiviruses 
with high bootstrap support (100%). 
 
CHAPTER 4: CONCLUSIONS AND FUTURE STUDIES 
 TaVCV has a regional prevalence, and is becoming an increasing issue, especially for the 
state of Hawaii. As taro is a vegetatively propagated plant, systemic viruses such as TaVCV 
results in infected offspring, which makes this virus a challenge to remove once established, and 
plant therapy may be required to reduce the prevalence of the virus. TaVCV negatively impacts 
the yield of taro crops, and, in severe cases of infection, infected plants could die. Thus, it is very 
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problematic for taro cultivation, which can be severely damaged if the virus spreads to different 
countries. Gradually, the virus is being found in more places, and Hawaii (Long et al., 2014) has 
had a recent discovery. While the South Pacific is responsible for a small portion of the world’s 
taro production, China and some countries in Africa consist of larger-scale taro cultivation. 
Regulations are in place that prohibit the movement of plants to other countries, but worldwide 
travel is now a regular occurrence, which may increase the risk of the virus spreading to places 
that have not yet been exposed. If TaVCV spreads to taro in countries with large-scale taro 
production, this would heavily impact taro cultivation as a whole. Therefore, more efforts must 
be made to reduce or eliminate this risk. Unfortunately, TaVCV and the taro virome remain 
understudied, despite the importance of this crop to both agriculture and society in the world. 
 This study has revealed the sequences of five isolates of TaVCV across the Pacific, as 
well as a novel taro-associated totivirus. Notably, Guam has also been found to have TaVCV in a 
taro sample used in this study, marking the first discovery of this virus at that location. All 
TaVCV isolates may have low genetic identity of at least 78%, but this fails to meet the 
demarcation criteria for the Nucleorhabdovirus genus which states that 50% nucleotide identity 
is required to denote a virus as a new species (“ICTV,” 2019). Though ICTV may recognize 
some viruses as unique species despite having a slightly higher degree of identity than the 
criteria, the identity of these viruses is still too high. This high genetic diversity highlights a 
current challenge in PCR diagnostics, which are sensitive to nucleotide deviations and such a 
variability can disturb primer-template interactions to yield false negatives. Covering a wider 
range of genomic data can aid in the design of alternative PCR diagnostics which account for the 
nucleotide diversity among these isolates. A high protein identity of at least 89% also opens up a 
possibility for some antibody-based diagnostics. 
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Combined with other methods for nucleic acid extraction and isolation of viruses through 
either purification or isolation of dsRNA fractions, HTS is a very promising tool for the study of 
viruses whose sequences are unknown. While HTS has issues which include gaps introduced in 
scaffolds due to a lack of information, the ability to use random sequences to find new viruses 
reduces the amount of guesswork required to perform whole genome virus sequencing. This 
study has successfully demonstrated the utility of HTS by both sequencing isolates of TaVCV 
with high diversity as well as the sequencing of a virus not previously documented and serves as 


















APPENDIX: DEVELOPMENT OF AN ANTIBODY-BASED ASSAY FOR THE 
DETECTION OF TARO VEIN CHLOROSIS NUCLEORHABDOVIRUS (TAVCV) 
 
Introduction 
 Some methods for detecting the presence of viruses in plant material include polymerase 
chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). PCR is a viable option 
for viral diagnostics, but the high nucleotide variability among isolates of taro vein chlorosis 
nucleorhabdovirus (TaVCV) poses a challenge for the reliable detection of this virus. Low 
nucleotide identity does not necessarily correspond to low protein identity, as some codons will 
translate to the same amino acid. Silent mutations such as those contribute to a lower nucleotide 
identity but not a lower protein identity. Here, where high nucleotide variability of TaVCV 
makes the design of a robust PCR assay challenging, ELISA may be more reliable. 
 ELISA for the detection of viruses works by using antibodies that specifically target a 
viral protein featured prominently on its surface (Fig. A1). The development of an ELISA via 
hybridoma technology involves a workflow of synthesizing a recombinant protein to be 
expressed and purified, injecting a solution with the protein into an animal host to raise B-cells 
that have antibodies specific to the protein, then fusing B-cells into a murine myeloma cell line. 
This yields a fused cell which can proliferate for a long time and continue to produce protein-
specific antibodies. Isolation of cell lines after the fusion yields a cell line producing monoclonal 
antibodies, which are antibodies that target a particular protein epitope. For convenience, this 
method is typically used for the development of an indirect (ID-)ELISA or a double antibody 
sandwich (DAS-)ELISA, so that conjugation of alkaline phosphatase or horseradish peroxidase 
does not need to be done for each new antibody. The antibodies could also be used for 
immunocapture reverse transcription (IC-RT-)PCR, which uses antibodies to coat the surface of 
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a PCR tube and selectively grab virus particles from a sample, which is then denatured by heat 
and used as a template for RT-PCR. 
 Here, we report the development of a monoclonal antibody hybridoma cell line for the 
detection of TaVCV through the synthesis of a nucleoprotein fragment from a Hawaiian isolate 
and the application of these antibodies via ELISA and IC-RT-PCR. 
 
 
Fig. A1. The different types of ELISA used for detection assays. Adopted from 
https://upload.wikimedia.org/wikipedia/commons/3/3b/Elisa_tipus.gif 
 
Materials and Methods 
Development of a Plasmid Construct for the Expression of Nucleoproteins 
RNA was extracted from taro leaves using the plant RNA isolation protocol for the 
NucleoSpin RNA Plus kit. The RNA eluate was used as a template for reverse transcription. 1 
µL RNA, 1 µL 100 µM random hexamers, 10 µL nuclease-free H2O were mixed, incubated at 95 
°C for 8-10 min, then immediately chilled on ice for at least 1 min and spun down by 
centrifugation. To this reaction, 4 µL 5x First-Strand Buffer, 2 µL 0.1 M dithiothreitol, 1 µL (40 
U/µL) rRNAsin Ribonuclease Inhibitor and 1 µL SuperScript III Reverse Transcriptase (200 
U/µL) were added. The reaction was incubated at 25 °C for 5-10 min, then 50 °C for 60 min, 
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then inactivated by incubating at 98 °C for 2 min, followed by chilling on ice and a brief 
centrifugation step. 
1 µL of the previous reaction, 1 µL 10 µM Cap2A(AsiSI) primer (5’-
TTTGCGATCGCCATGGACGCCACTATAGCCTCCGACTGGG-3’), 1 µL 10 µM 
Cap2S(PmeI) primer (5’-TTTGTTTAAACTTATCATTGGTTGGATGTCCCTCCGC-3’), 7 µL 
nuclease-free H2O, 10 µL 2x GoTaq Green Master Mix were mixed and incubated in a 
thermocycler with the following cycling conditions: 95 °C for 7 min, then 30 cycles of 95 °C for 
30 sec, 55 °C for 45 sec and 72 °C for 1 min, followed by 72 °C for 10 min. These reactions 
were run on an agarose gel and a band corresponding to the expected size (1.1 kb) was cut from 
the gel, extracted by a centrifugation step through filter paper at maximum speed (21,130 g) for 2 
min. 
0.3 µL of pGEM T-Easy vector, 3.7 µL gel eluate, 5 µL 2x Rapid Ligation Buffer and 1 
µL T4 DNA Ligase (3 U/µL) were mixed and incubated overnight at RT. The following day, a 
tube containing chemically competent E. coli DH5α cells was thawed on ice for 10 min, then 2-5 
µL of the ligation reaction was added to the tube of cells, flicked gently 4-6 times and incubated 
on ice for 60 min. The tube was then added to a water bath at exactly 42 °C and incubated for 30-
45 sec before immediately placing the tubes back on ice for 2 min. Super Optimal Broth (450 
µL) was then added to the tube and incubated at 37 °C for 45 min with shaking (200-300 rpm). 
250 µL was then plated on MacConkey Agar containing ampicillin antibiotics at a concentration 
of at least 100 µg/mL, then incubated overnight at 37 °C. 
Bacteria colony PCR using T7 and SP6 primers was then performed for each white 
colony that grew on the agar, and colonies that amplified products at roughly the expected size 
were then grown in Luria-Bertani medium (LB) containing ampicillin at a concentration of at 
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least 100 µg/mL overnight. The QIAgen Spin Miniprep Kit was used to purify the plasmid 
containing the insert of interest and the plasmid that was eluted from the kit was then sequenced. 
The plasmids containing the PCR insert were then used for a restriction digest. 
A volume containing 1 µg of pGEM T-Easy containing the PCR insert, 2 µL 10X Buffer 
B, 0.5 µL SfaAI (AsiSI) (10 U/µL), 0.5 µL MssI (PmeI) (5 U/µL), and a volume of nuclease-free 
water such that the final volume was 20 µL were mixed and incubated at 37 °C for 1 hour, then 
inactivated by incubating at 80 °C for 20 min. The restriction enzymes and 10X Buffer B were 
supplied by Thermo Scientific. The restriction digest was run on an agarose gel and a band 
corresponding to the expected size of the PCR insert (1.1 kb) was cut from the gel, extracted by 
the QIAquick Gel Extraction Kit. Another restriction digest was also done by replacing pGEM 
T-Easy with pFN6A vector. 
A volume of double-digested pFN6A vector, a volume of double-digested PCR insert, 1 
µL 10x T4 DNA Ligase Buffer and 1 µL T4 DNA Ligase (3 U/µL) were mixed such that the 
final volume was 10 µL with a molar ratio of 1:3 vector to insert and incubated overnight at RT. 
The following day, a tube containing chemically competent E. coli KRX cells was thawed on ice 
for 10 min, then 2-5 µL of the ligation reaction was added to the tube of cells, flicked gently 4-6 
times and incubated on ice for 60 min. The tube was then added to a water bath at exactly 42 °C 
and incubated for 30-45 sec before immediately placing the tubes back on ice for 2 min. Super 
Optimal Broth (450 µL) was then added to the tube and incubated at 37 °C for 45 min with 
shaking (200-300 rpm). 250 µL was then plated on MacConkey Agar containing ampicillin 
antibiotics at a concentration of at least 100 µg/mL, then incubated overnight at 37 °C. 
Bacteria colony PCR using modified T7 (5’-TAATACGACTCACTATAGG-3’) and 
Cap2S(PmeI) primers was then performed for each colony that grew on the agar, and colonies 
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that amplified products at roughly the expected size were then grown in Luria-Bertani medium 
(LB) containing ampicillin at a concentration of at least 100 µg/mL overnight. The QIAgen Spin 
Miniprep Kit was used to purify the plasmid containing the insert of interest and the plasmid that 
was eluted from the kit was then sequenced. Colonies that contained the pFN6A plasmid with the 
PCR insert in frame with the (HQ)3-tag were used for protein expression and purification. 
 
Protein Expression and Purification 
 250 mL LB, 500 µL 100 µg/mL ampicillin, 1.25 mL 20% rhamnose, and 2.5 mL 20% 
glucose were mixed, inoculated with an E. coli KRX colony containing the pFN6A plasmid 
construct containing the PCR insert, then incubated at 37 °C for 2 days and shaken at 150 rpm. 
The culture is then centrifuged at 4,000 rpm for 20 minutes in an autoclaved 250 mL centrifuge 
bottle. The supernatant was removed, then the bacterial pellet was resuspended in 10 mL of 
Binding Buffer (100 mM HEPES pH 7.5, 1% Triton-X, 10 mM imidazole, 200 mM NaCl), after 
which 1.12 mL FastBreak solution (1,027 µL 10X FastBreak Reagent, 93 µL DNase I) was 
added and the solution was moved to a 50 mL conical tube. EDTA-free Pierce Protease Inhibitor 
Tablets (1 tablet per 10 mL) can be added to the Binding Buffer. This solution was freeze-
thawed at least three times using a -80 °C freezer. 0.5 mL of 50% slurry of HisLink Resin was 
added to the solution and incubated at 4 °C for at least 30 minutes on an orbital shaker. 
 The conical tube was propped upright to let the resin sink to the bottom for at least 5 
minutes, after which the supernatant was removed. The resin was resuspended in 5 mL of Wash 
Buffer (100 mM HEPES pH 7.5, 1% Triton-X, 10 mM imidazole, 1 M NaCl) and sunk to the 
bottom of the conical tube for at least 5 minutes, after which the supernatant was removed. 
EDTA-free Pierce Protease Inhibitor Tablets (1 tablet per 10 mL) can be added to the Wash 
Buffer. The wash step was repeated twice for a total of three washes. After this, wash buffer was 
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added to the resin to resuspend and transfer it to a spin column provided in the HisLink Spin 
Protein Purification System kit. The column was briefly centrifuged for 5 seconds and the 
flowthrough was discarded. 
0.5 mL of Elution Buffer (100 mM HEPES pH 7.5, 100 mM imidazole) was added to the 
resin and the spin column was briefly centrifuged for 5 seconds. The eluate was transferred to a 
separate 1.5 mL microcentrifuge tube. The elution step was repeated twice to yield 1.5 mL of 
eluate containing the (HQ)3-tagged protein. The eluate was run by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) to check for purity and size of the protein 
product. 
 
Development of a Hybridoma Producing TaVCV-Specific Monoclonal Antibodies 
 In a 15 mL conical tube, 1 mL of solution containing 100 µg (HQ)3-tagged protein was 
mixed with 1 mL of a 10% (w/v) solution of KAl(SO4)2 (alum) in distilled water, after which 10 
drops (approximately 200 µL) of 1 M NaOH were added. This solution was mixed by vortexing, 
then left to incubate for 1 hour at RT. The solution was then centrifuged at 1,500 rpm for 5 
minutes to pellet precipitated proteins, and the supernatant was removed. The pellet was 
resuspended in 1 mL phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4; pH 7.4) and centrifuged once more at 1,500 rpm for 5 minutes, after 
which the supernatant was removed. The pellet was resuspended in PBS to a final volume of 825 
µL. 250 µL of this solution was used to immunize each mouse via intraperitoneal injection. 
Injections were repeated every two weeks after the initial injection for a total of three injections. 
All solutions used for this method were sterilized before use, and aseptic technique was 
used to prevent contamination. Spleens were harvested from each mouse and washed in GKN 
(NaCl 8 g, KCl 0.4 g, Na2HPO4 1.41 g, NaH2PO4・H2O 0.69 g, glucose 2 g, phenol red 0.01 g or 
81 
 
100 µL of 0.1 g/mL stock solution, dH2O to 1 L; pH 7.4) in a Petri dish to remove blood or 
debris. After washing, the spleen was transferred to a second Petri dish containing 6-7 mL GKN, 
which was used to extract the splenocytes by using a 10 mL syringe with an 18 or 20 gauge 
needle to stick the spleen lengthwise and gently perfuse with GKN until the spleen appeared 
translucent to yield a single cell suspension. The Petri dish was canted on one side to settle large 
debris and the supernatant was transferred to a sterile 15 mL centrifuge tube, adding GKN for a 
final volume of 15 mL. A cell count was taken for the cell suspension and a volume containing 5 
x 107 cells was transferred to a sterile 50 mL centrifuge tube. A culture of P3-X63-Ag8.653 
myeloma cells was also prepared, a cell count was taken, the cells were washed and suspended in 
GKN, and a volume containing 1 x 107 cells was added to the 50 mL centrifuge tube containing 
the splenocytes. The volume was adjusted to 50 mL with GKN, then the cells were spun down at 
400 g for 10 min at RT, after which the supernatant was decanted gently. The cells were 
loosened by hitting the bottom of the tube several times. 
 Splenocytes were fused together with P3-X63-Ag8.653 myeloma cells in solution by 
gently mixing the cell suspension and slowly adding 1 mL of polyethylene glycol (PEG) solution 
(melted PEG [ATCC, MW 1300-1600, sterile] 2 g, GKN 2 mL, DMSO 0.5 mL) with a 1 mL 
sterile pipette over 1 minute, with continued stirring for 90 seconds in a 37 °C water bath. Two 
aliquots of 1 mL GKN warmed to 37 °C were slowly added to the cell suspension each over 1 
minute, then 7 mL GKN warmed to 37 °C was slowly added over 2-3 minutes. This was 
incubated at RT for 5 min, then 40 mL of GKN at RT was added to the cell suspension, then 
spun at 400 g for 10 min. The supernatant was decanted and the cell pellet was resuspended in 20 
mL hypoxanthine-aminopterin-thymidine (HAT) media (hypoxanthine 0.1361 g, thymidine 
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0.0388 g, dH2O to 100 mL, 1 mL aminopterin 100X stock solution; aminopterin 100X = 
aminopterin 1.76 mg, dH2O added and NaOH added to dissolve, dH2O to 100 mL). 
The mixture was added to HAT media in a 96-well macrophage plate incubated 1-3 days 
in advance at 37 °C in 5% CO2 to selectively proliferate successfully fused hybridomas. The cells 
were incubated at 37 °C for 1 to 2 weeks with 5% CO2. Each well was checked periodically to 
find wells that contained successfully fused hybridomas. Hybridomas were weaned off HAT 
media by replacing half of the media with Dulbecco’s Modified Eagle Medium supplemented 
with 10% fetal bovine serum (DMEM-10) every 2 to 3 days. Wells containing hybridomas were 
initially screened via indirect (ID-)ELISA to determine hybridomas that had antibody reactivity 
with TaVCV and the (HQ)3-tagged protein used for immunizations. Cell count was determined 
for each well, then a single cell suspension was prepared to isolate monoclonal hybridomas, 
depositing cell concentrations of 5, 1, and 0.5 cells/well on a 96-well tissue culture plate. These 
were also screened via ID-ELISA for reactivity with TaVCV and the (HQ)3-tagged protein. 
 
ID-ELISA 
 For leaf samples, 0.1 g of leaf tissues (from sweet potato, healthy taro, or infected taro) 
were homogenized in 1 mL carbonate coating buffer (Na2CO3 1.59 g, NaHCO3 2.93 g, NaN3 0.2 
g, dH2O to 1 L, pH 9.6), then centrifuged at 4,500 g for 2 min. For E. coli, an E. coli suspension 
of 0.1 OD in carbonate coating buffer was prepared. For purified proteins (the (HQ)3-tagged 
protein used as antigen and another (HQ)3-tagged protein p23 from HGSV-2), a suspension 
containing 10 µg/mL of protein in carbonate coating buffer was prepared. 100 µL of each of 
these solutions were plated on a 96-well microplate and incubated at 37 °C for 1-2 hours (or, 
alternatively, 4 °C overnight) and washed at least 3 times with PBS-T (10X PBS 100 mL, 
Tween-20 0.5 mL, dH2O 900 mL; 10X PBS = NaCl 80.0 g, KCl 2.0 g, Na2HPO4・2H2O 14.4 g, 
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KH2PO4 2.4 g, NaN3 0.2 g, dH2O to 1 L, pH 7.4). 200 µL of PBS-T containing 5% (w/v) non-fat 
dry milk was added to each well for blocking and incubated at 37 °C for 1-2 hours (or, 
alternatively, 4 °C overnight) and washed at least 3 times with PBS-T. 
 100 µL of hybridoma media or 1:1000 dilution of mouse sera was added to each well and 
incubated at 37 °C for 1-2 hours (or 4 °C overnight) and washed at least 3 times with PBS-T. 
After that, 100 µL of a 1:1000 dilution of a goat-anti-mouse IgG conjugated to alkaline 
phosphatase was added to each well, incubated at 37 °C for 1-2 hours (or 4 °C overnight) and 
washed at least 8 times with PBS-T. 100 µL of p-nitrophenyl phosphate (PNPP) solution (10 mg 
PNPP in 10 mL PNPP substrate buffer [MgCl2・6H2O 0.1 g, NaN3 0.2 g, diethanolamine 97 mL, 
dH2O to 1 L, pH 9.8]) was added to each well. OD readings were taken at 405 nm in 15-minute 
intervals after the application of PNPP solution, up to 60 minutes. 
 
IC-RT-PCR 
 Hybridoma supernatant was concentrated using an Amicon Ultra centrifugal filter (50 
kDa molecular weight cutoff). 1 µL of concentrated supernatant was added to 19 µL of carbonate 
coating buffer in a PCR tube, incubated at 37 °C for 2-3 hours, then washed at least 3 times with 
PBS-T.  0.1 g of leaf tissues were homogenized in 1 mL PBS-T, then centrifuged at 4,500 g for 2 
min. 20 µL of leaf tissue supernatant was added to the PCR tube, incubated at 4 °C overnight, 
then washed at least 3 times with PBS-T, then at least 1 time with molecular-grade dH2O. The 
RT-PCR was performed using SuperScript III One-Step RT-PCR System as follows. 1 µL 10 
µM DCGF5 (5’-AGGGGYTGAGRCAAAAGGGGT-3’), 1 µL 10 µM DCGR5 (5’-
CGCTCYTTCATACATGCSGCCTT-3’), 7.2 µL nuclease-free H2O were added to the PCR 
tube, incubated at 95 °C for 8-10 min, then immediately chilled on ice for at least 1 min and 
centrifuged. To this reaction, 10 µL 2x Reaction Mix and 0.8 µL SuperScript III RT/Platinum 
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Taq Mix were added. The reaction was then incubated at 55 °C for 30 min, then 94 °C for 2 min, 
followed by 40 cycles of 94 °C for 15 sec, 55 °C for 30 sec, 68 °C for 1 min, then 68 °C for 5 
min. 
 
Results and Discussion 
 Detection assays are important for the health industry when human pathogens are 
concerned, and for crop cultivation when plant pathogens are concerned. The theory behind the 
development of ELISA and PCR assays have a sufficient foundation, but certain factors can 
complicate the use of these assays. The use of a PCR assay for TaVCV is hindered by high 
nucleotide diversity among its strains, so there is a greater potential utility for an ELISA. 
When this work was being performed, little information about the genome of TaVCV 
was available at the time except for the genome of the Fijian isolate. However, a Fijian strain of 
TaVCV was unavailable at the time of developing the plasmid construct for the (HQ)3-tagged 
TaVCV nucleoprotein, and a primer set designed to amplify the entire nucleoprotein was 
unsuccessful when screening through cDNA samples that were acquired from Hawaiian samples. 
Cap2A(AsiSI)/S(PmeI) was a primer set designed with restriction sites that yielded a successful 
amplification from a Kauai sample positive for TaVCV. The set was based on a previously 
established primer set Cap2A/B which was used for an RT-PCR assay before the development of 
the DCGF/R primers, targeting a segment of the nucleoprotein-coding gene. The development of 
the Cap2A/S primer set was to add a stop codon and restriction sites for the pFN6A plasmid 
construct. Thus, the (HQ)3-tagged protein used in this chapter is a partial segment of the 
nucleocapsid rather than the complete nucleocapsid. 
Notably, the protein eluate when checked by SDS-PAGE appeared to have a major 
protein band corresponding to a protein size of approximately 23 kDa (Fig. A2a). This is a 
85 
 
surprising difference in molecular weight to the theoretical molecular weight of 41 kDa. A few 
possibilities exist to account for this occurrence. The protein could have been cleaved by E. coli 
proteases during the process of expression and purification, the protein could be unstable and be 
cleaved as a result, or codons that are common to taro that may be rare to E. coli could be 
responsible for the incomplete expression of a protein. A band appearing at around 43 kDa in 
another SDS-PAGE (Fig. A2b) done for protein eluate extracted after a protein purification using 
the EDTA-free Pierce Protease Inhibitors implies that proteases may be partly responsible for the 
degradation of the protein, but a large amount of protein at approximately 23 kDa remained 
despite that, implying another reason may also be involved that does not involve proteases. 
The initial screening (Table A1) revealed two wells, P1D5, and P2G5, which had 
significant reactivity against the protein and taro samples used. Three other wells with much 
weaker activity, P3A1, P4C7, and P4E6, were also maintained and subcloned in case some of the 
resulting subclones had a notable degree of reactivity downstream. Interestingly, negative 
controls using terminal bleeds consistently had higher reactivity against the taro sample that 
tested negative by RT-PCR. A subcloning attempt of P4E6 (Table A2) yielded two promising 
subclones, P4E6-B2 and P4E6-C2, both of which had high reactivity against TaVCV-positive 
taro in contrast to TaVCV-negative taro. While all subclones of P4E6-B2 had strong reactivity to 
TaVCV (Table A3), P4E6-B2.5 represents a subclone of P4E6-B2 that has the lowest cross-
reactivity to E. coli KRX, sweet potato leaf, and (HQ)3-tagged p23 protein. The IC-RT-PCR trial 
using P1D5-F4, P2G5, and P4E6-B2.5 hybridoma supernatants (Fig. A3) gives support to the 
viability of the P4E6-B2.5 as a potential monoclonal antibody for TaVCV diagnostic assays. 
 In ELISA trials using RT-PCR negative taro sampled from Kapiolani Community 
College, any antibody with reactivity to RT-PCR positive taro did not have as strong of a 
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reaction to the RT-PCR negative taro, though some activity was still present, indicating the 
possibility of a lower titer of TaVCV rather than being truly negative for the virus. There was 
some concern regarding the strong reactivity of the antibodies when the negative control was 
replaced by thermotherapy-treated taro samples. The samples treated by thermotherapy were 
negative in RT-PCR when tested with TaVCV detection primer sets, and the leaves that were 
used for ELISA appeared to be healthy. A strong reactivity against the RT-PCR negative sample 
raises the possibility that the antibody could target a protein native to taro, but this needs to be 






Fig. A2a. Silver Stain of a SDS-PAGE gel made using the Pierce Silver Stain Kit from Thermo 
Scientific. Lane assignments are as follows: SuperSignal Molecular Ladder with sizes provided 
in kDa (Lane 1), E. coli KRX lysate without construct (Lane 2), with construct and expressing 
(Lane 3), flowthrough (Lane 4) and (HQ)3-tagged nucleoprotein (Lane 5). A distinct, pure band 
of 23 kDa is found in the nucleoprotein eluate, which was notably different from the expected 41 
kDa molecular weight of the protein construct. 
 
 
Fig. A2b. Silver Stain of a SDS-PAGE gel made using the Pierce Silver Stain Kit from Thermo 
Scientific. Lane assignments are as follows: SuperSignal Molecular Ladder with sizes provided 
in kDa (Lane 1), E. coli KRX lysate without construct (Lane 2), with construct and expressing 
(Lane 3), TaVCV-negative taro leaf (Lane 4), TaVCV-positive taro leaf (Lane 5), and (HQ)3-
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tagged nucleoprotein (Lane 6). The nucleoprotein was purified using a purification protocol that 
used EDTA-free Pierce Protease Inhibitor Tablets in the Binding and Wash Buffers. Distinct 
bands of 23 and 43 kDa are found in the nucleoprotein eluate, the latter of which was close to the 
expected 41 kDa molecular weight of the protein construct. 
 
 
Table A1. Initial screening of hybridomas by ID-ELISA. Data was taken at 30 min. P1D5 and 
P2G5 represent hybridoma cultures containing cells producing a high amount of antibody 
reactive with taro and the (HQ)3-tagged nucleoprotein. P3A1, P4C7, and P4E6 represent 
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hybridoma cultures with some activity to taro (with a higher degree to TaVCV-positive taro) but 
very little activity to the (HQ)3-tagged nucleoprotein. Here, the RT-PCR negative taro was 
sampled from Kapiolani Community College. A blood sample after the last injection was used as 
the positive control, while pre-immune serum was used as the negative control. 
 
 
Table A2. Screening by ID-ELISA of the hybridomas isolated in the first subcloning. Data was 
taken at 30 min. The subclones of P1D5 and P4E6 represented a culture of hybridomas with 
antibody reactivity to the RT-PCR positive taro much more compared to the RT-PCR negative 
taro. Here, the RT-PCR negative taro was sampled from Kapiolani Community College. A blood 
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sample after the last injection was used as the positive control, while pre-immune serum was 
used as the negative control. 
 
 
Table A3. Screening by ID-ELISA of the hybridomas isolated in the second subcloning. Data 
was taken at 30 min. The P4E6-B2 subclones each had reactivity to RT-PCR positive taro, 
though little reactivity was noted with (HQ)3-tagged nucleoprotein. While P4E6-B2.5 represented 
a hybridoma culture with the least reactivity to RT-PCR positive taro, it also represented the 
culture with the least cross-reactivity to other samples used in this trial. Here, the RT-PCR 
negative taro was sampled from Kapiolani Community College. A blood sample after the last 
injection was used as the positive control. As limited amounts of pre-immune serum was 
available at the time, dH2O was used as the negative control. 
 
 
Table A4. Screening by ID-ELISA of various hybridoma cell lines raised throughout the course 
of the experiments. Data was taken at 30 min. Here, the RT-PCR negative taro was a leaf sample 
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from a taro plant that has undergone thermotherapy to eliminate TaVCV. Surprisingly, the RT-
PCR negative taro had very high reactivity with some of the hybridoma cultures, especially 
P4E6-B2.5. A blood sample after the last injection was used as the positive control. As limited 
amounts of pre-immune serum was available at the time, dH2O was used as the negative control. 
 
 
Fig. A3. Results of IC-RT-PCR using concentrated hybridoma supernatant, RT-PCR positive 
taro leaf lysate, and DCGF/R5 primer set. Lane assignments are as follows: GeneRuler 100 bp 
(Lane 1), P1D5-F4 supernatant (Lane 2), P2G5 supernatant (Lane 3), P4E6-B2.5 supernatant 
(Lane 4), carbonate coating buffer as negative control (Lane 5). P4E6-B2.5 appears to be the 
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